LICENSE: This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.


101536955
38433
Wiley Interdiscip Rev RNA
Wiley Interdiscip Rev RNA
Wiley interdisciplinary reviews. RNA
1757-7004
1757-7012

36123820
10024649
10.1002/wrna.1762
NIHMS1834346
Article
mRNA isoform balance in neuronal development and disease
LaForce Geneva R http://orcid.org/0000-0002-5046-5194
Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA

Philippidou Polyxeni http://orcid.org/0000-0002-0733-3591
Department of Neurosciences, Case Western Reserve University, Cleveland, OH, 44106, USA

Schaffer Ashleigh E http://orcid.org/0000-0002-1164-697X
Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA

Author Contributions

Geneva R LaForce: Conceptualization (equal); funding acquisition (supporting); visualization (lead); writing – original draft (lead); writing – review and editing (equal). Polyxeni Philippidou: Visualization (supporting); funding acquisition (equal); writing – original draft (supporting); writing – review and editing (supporting). Ashleigh E Schaffer: Conceptualization (lead); funding acquisition (equal); writing – original draft (equal); writing – review and editing (equal).

geneva.laforce@case.edu
13 9 2022
May-Jun 2023
19 9 2022
01 5 2024
14 3 e1762e1762
This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.
Balanced mRNA isoform diversity and abundance are spatially and temporally regulated throughout cellular differentiation. The proportion of expressed isoforms contribute to cell type specification and determine key properties of the differentiated cells. Neurons are unique cell types with intricate developmental programs, characteristic cellular morphologies, and electrophysiological potential. Neuron-specific gene expression programs establish these distinctive cellular characteristics and drive diversity among neuronal subtypes. Genes with neuron-specific alternative processing are enriched in key neuronal functions, including synaptic proteins, adhesion molecules, and scaffold proteins. Despite the similarity of neuronal gene expression programs, each neuronal subclass can be distinguished by unique alternative mRNA processing events. Alternative processing of developmentally-important transcripts alters coding and regulatory information, including interaction domains, transcript stability, subcellular localization, and targeting by RNA binding proteins. Fine-tuning of mRNA processing is essential for neuronal activity and maintenance. Thus, the focus of neuronal RNA biology research is to dissect the transcriptomic mechanisms that underlie neuronal homeostasis, and consequently, pre-dispose neuronal subtypes to disease.


pmc1. INTRODUCTION

Gene expression is a concerted effort of several protein and nucleic acid complexes. Protein-coding genes are transcribed by RNA polymerase II in the nucleus to produce precursor mRNA molecules, which undergo specific processing events to generate mature mRNA for nuclear export and cytoplasmic translation. Pre-mRNA is co- and post-transcriptionally processed by two main complexes – the spliceosome and the cleavage and polyadenylation (CPA) complex. The spliceosome contains over 140 distinct proteins and small RNA molecules that comprise the five main subcomplexes – U1, U2, U4, U5, and U6 snRNPs, or small nuclear Ribonucleoproteins – and is mainly responsible for excising introns to produce the in-frame coding sequence of the mature mRNA (Ritchie, Schellenberg, &amp; MacMillan, 2009; van der Feltz, Anthony, Brilot, &amp; Pomeranz Krummel, 2012; Zhou, Licklider, Gygi, &amp; Reed, 2002). The CPA machinery contains over 80 proteins, which assemble as four distinct subcomplexes – CPSF, CstF, CFIm, and CFIIm – to recognize the polyadenylation signal, cleave the mRNA, and append a polyadenylate (polyA) tail (Shi et al., 2009; Y. Sun, Hamilton, &amp; Tong, 2020). mRNA isoform diversity arises from differential transcriptional initiation and processing of pre-mRNA molecules produced from a single gene. The composition of gene isoforms often changes throughout differentiation and development (Agarwal, Lopez-Darwin, Kelley, &amp; Shendure, 2021; Ji, Lee Ju, Pan, Jiang, &amp; Tian, 2009; Ji &amp; Tian, 2009; Sandberg, Neilson Joel, Sarma, Sharp Phillip, &amp; Burge Christopher, 2008; Shepard et al., 2011; Stark, Brennecke, Bushati, Russell, &amp; Cohen, 2005; J. Wang et al., 2021), and the proportions of expressed isoforms across all genes is a fundamental determinant of cell type specification (Belgard et al., 2011; Gupta et al., 2018; S. He, Ruknudin, Bambrick, Lederer, &amp; Schulze, 1998; Ji &amp; Tian, 2009; Kazantseva et al., 2009; Lerch et al., 2012; Lianoglou, Garg, Yang, Leslie, &amp; Mayr, 2013; Nakahata &amp; Kawamoto, 2005; Reyes &amp; Huber, 2018; Schreiner et al., 2014; Shulman &amp; Elkon, 2019; Stark et al., 2005; Y. Zhang et al., 2014). Regulation of gene expression by differential mRNA processing can be achieved by switch-like regulation of specific isoforms or finely-tuned co-expression of multiple isoforms (Derti et al., 2012; Jangi, Boutz, Paul, &amp; Sharp, 2014; Lerch et al., 2012; Lewis, Green, &amp; Brenner, 2003; Schreiner et al., 2014; Spellman, Llorian, &amp; Smith, 2007; Tapial et al., 2017; E. T. Wang et al., 2008; Yap, Xiao, Friedman, Je, &amp; Makeyev, 2016).

Approximately 93% of human genes undergo alternative splicing (AS) and 79% undergo alternative polyadenylation (APA) (Hoque et al., 2013; Q. Pan, Shai, Lee, Frey, &amp; Blencowe, 2008; Reyes &amp; Huber, 2018; Shepard et al., 2011; Tian, Hu, Zhang, &amp; Lutz, 2005; E. T. Wang et al., 2008). Proliferative cells, such as stem cells and cancer cells, favor the usage of promoter-proximal polyadenylation sites, producing comparatively shorter 3’ UTRs (Hoffman et al., 2016; Ji &amp; Tian, 2009; W. Li et al., 2015; Mayr &amp; Bartel, 2009; Sandberg et al., 2008). In contrast, the majority of differentiated cell types, including neurons, express comparatively long 3’ UTRs derived from promoter-distal polyadenylation sites (Agarwal et al., 2021; Hoque et al., 2013; Ji et al., 2009; Ji &amp; Tian, 2009; Ramsköld, Wang, Burge, &amp; Sandberg, 2009; Shepard et al., 2011). AS and APA can alter several properties of the mRNA and encoded protein, including RNA stability (Braunschweig et al., 2014; Hoffman et al., 2016; Jangi et al., 2014; Ji &amp; Tian, 2009; Lewis, Burge, &amp; Bartel, 2005; Lewis et al., 2003; W. Li et al., 2016; Majoros &amp; Ohler, 2007; Nam et al., 2014; Sandberg et al., 2008; Spellman et al., 2007; Spies, Burge, &amp; Bartel, 2013; Stark et al., 2005; J. K. Vuong, Ergin, Chen, &amp; Zheng, 2022; J. Wang et al., 2021; R. Wang, Zheng, Yehia, &amp; Tian, 2018; Xie et al., 2005; S. Zheng et al., 2012), subcellular localization (Berkovits &amp; Mayr, 2015; Mattioli et al., 2019; Minis et al., 2014; Paradies &amp; Steward, 1997), RNA binding protein (RBP) interactions (Barash et al., 2010; Merkin, Russell, Chen, &amp; Burge Christopher, 2012; Spellman et al., 2007; J. Wang et al., 2021; E. Yang et al., 2003), translation efficiency (Blair, Hockemeyer, Doudna, Bateup, &amp; Floor, 2017; Spies et al., 2013; J. Wang et al., 2021), and coding information (Mattioli et al., 2019; Nakahata &amp; Kawamoto, 2005; Schreiner et al., 2014; Ushkaryov &amp; Südhof, 1993). Nonsense-mediated decay (NMD) and miRNA-mediated repression are the most common mechanisms by which aberrantly expressed transcripts are targeted for degradation. NMD is generally stimulated by the presence of a premature stop codon in an alternatively spliced transcript (Braunschweig et al., 2014; Jangi et al., 2014; Lewis et al., 2003; Spellman et al., 2007), while miRNAs bind to 3’ UTR sequences to render cell type-specific alternatively polyadenylated transcripts sensitive to repression (Hoffman et al., 2016; Ji &amp; Tian, 2009; Lewis et al., 2005; W. Li et al., 2016; Majoros &amp; Ohler, 2007; Nam et al., 2014; Sandberg et al., 2008; Spies et al., 2013; Stark et al., 2005; J. Wang et al., 2021; Xie et al., 2005). RBPs that function in regulating cell type-specific alternative splicing, are commonly autoregulated by alternative splicing of evolutionarily conserved out-of-frame exons that elicit NMD (poison exons) (Boutz et al., 2007; Jangi et al., 2014; Spellman et al., 2007). In contrast, miRNA-mediated repression is a mechanism to regulate the expression of most cell type-specific isoforms (Ji &amp; Tian, 2009; Licatalosi et al., 2008; Miura, Shenker, Andreu-Agullo, Westholm, &amp; Lai, 2013; Nam et al., 2014; Rodrigues et al., 2016). Here, we will describe mechanisms of gene expression regulation in neurons. As cell types with unique morphological and physiological phenotypes, neurons require precise regulation of mRNA expression to maintain identity and function. We also explore the connection between isoform imbalance and human neurological disease.

2. NEURONS HAVE UNIQUE DEVELOPMENTAL AND PHYSIOLOGICAL PROPERTIES

The mammalian nervous system is composed of several major cell classes, including neuronal, glial, epithelial, vascular and immune (Oldham et al., 2008; Tasic et al., 2016; Zeisel et al., 2018; Zeisel et al., 2015). During neurodevelopment, these cells assemble into highly organized structures with specific functions in the brain and spinal cord. For example, establishment of the mammalian respiratory circuit requires coordinated assembly of pre-motor neuron populations in the brainstem to generate inspiratory rhythms and motor neuron populations in the spinal cord to exert motor control of the diaphragm (van der Heijden &amp; Zoghbi, Vagnozzi et al). Recent advancements in neuroanatomical mapping have identified &gt;150 regions of the human cortex distinguished by function, connectivity, and/or topography (Glasser et al., 2016; A. Irimia, Chambers, Torgerson, &amp; Van Horn, 2012). Additionally, over 40 neuronal populations have been characterized in the spinal cord, retina and olfactory system (Beites, Kawauchi, &amp; Calof, 2009; Dobrott, Sathyamurthy, &amp; Levine, 2019; Nguyen-Ba-Charvet &amp; Rebsam, 2020; Russ et al., 2021). Neurons acquire specialized morphology and electrical activity and exhibit distinct migratory patterns and developmental progression (Ascoli et al., 2008; Migliore &amp; Shepherd, 2005; Sousa, Meyer, Santpere, Gulden, &amp; Sestan, 2017; Zeng &amp; Sanes, 2017). Underlying these unique properties are neuron-specific gene expression programs which drive neuronal diversity via cellular identity, connectivity, and neurotransmission &amp; membrane conductance (Closser et al., 2022; Saunders et al., 2018; Tasic et al., 2016; Zeisel et al., 2018). For example, Zeisel and colleagues surveyed the mouse nervous system via single-cell RNA sequencing and found cell populations cluster by brain region (i.e. cortex, hindbrain, olfactory bulb, etc.) followed by neurotransmitter expression (e.g. glutamate, GABA, acetylcholine, etc.) (Zeisel et al., 2018). Throughout neurodevelopment, these expression programs change, guided by cis regulatory elements and trans-acting factors (Takeuchi et al., 2018; X. Zhang et al., 2016). Furthermore, aging neurons have been shown to reverse these gene expression programs, leading to altered metabolism and response to nucleic acid oxidation (Berchtold et al., 2008; T. Lu et al., 2004; Mecocci et al., 1993; Nunomura et al., 2012). These gene expression changes likely modify neural networks and contribute to age-related decline in cognition (Colantuoni et al., 2011; Loerch et al., 2008; Nunomura et al., 2012; Somel et al., 2010).

2.1 Neuronal Cell Type Specification and Diversity

Traditionally, neurons were classified by morphology, spatial position, and electrophysiological behavior (Migliore &amp; Shepherd, 2005; Molyneaux, Arlotta, Menezes, &amp; Macklis, 2007; Zeng &amp; Sanes, 2017). Morphological properties include the size of the soma, patterning of dendrites and axons, as well as dendritic spine density. These features, combined with spatial position, were used to classify cortical neurons into two groups: neurons with local connections and neurons that extend axons to distant targets. Electrophysiological characterization utilizing patch clamp recordings could further segregate cortical neurons by their resting potential, firing rate, and spike patterns (Migliore &amp; Shepherd, 2005; Zeng &amp; Sanes, 2017). However, these classification methods do not account for the molecular diversity of mammalian neurons. Recently, over 100 transcriptionally-distinct neuronal subtypes were identified in the brain using advanced single-cell RNA sequencing techniques (Saunders et al., 2018). Molecular neuronal diversity arises from unique expression of transcription factors and alternative processing of mRNA, producing gene expression modules enriched in neuron-specific functions, including axon guidance, synaptic transmission, and transmembrane potential (Furlanis, Traunmüller, Fucile, &amp; Scheiffele, 2019; M. B. Johnson et al., 2009; Song et al., 2017; Tasic et al., 2016; Zeisel et al., 2018). For example, Furlanis and colleagues identified genes with differential splicing regulation across neocortical cell classes were enriched in gene ontology terms in five categories: adhesion complexes, voltage-gated ion channels (i.e. calcium and potassium channels), pre-synaptic release machinery, postsynaptic neurotransmitter receptor complexes, and scaffolding proteins (Furlanis, Traunmüller, Fucile, &amp; Scheiffele, 2019). Moreover, neuronal genes are disproportionately long and alternative mRNA processing produces an abundant diversity of isoforms (Gabel et al., 2015; King et al., 2013; Lerch et al., 2012; X. Liu et al., 2011; Miura et al., 2013; Schreiner et al., 2014; Takeuchi et al., 2018; Ushkaryov &amp; Südhof, 1993). Thus, in many cases, molecular diversity alone can be used to distinguish neuronal subtypes (Oldham et al., 2008; Saunders et al., 2018; Tasic et al., 2016; Zeisel et al., 2015).

While spontaneous activity prior to synaptogenesis contributes to synapse formation, expression of neurotransmitters by mature neurons shapes the output of neural circuitry (de Graaf-Peters &amp; Hadders-Algra, 2006; Hua &amp; Smith, 2004). Neurotransmitters are released by the pre-synaptic neuron into the chemical microenvironment and are recognized by ligand-gated ion channel receptors on the post-synaptic neuron (B. Lu, Wang, &amp; Nose, 2009; L. Nguyen et al., 2001). Three main classes of neurotransmitters are found in the human nervous system – excitatory, inhibitory, and modulatory neurotransmitters. Excitatory neurotransmitters, such as glutamate, are released into the synapse to increase neuronal activity while inhibitory neurotransmitters, such as γ-aminobutyric acid (GABA), are used to temper neuronal activity. Modulatory neurotransmitters influence other neurotransmitters, working together to enhance the excitatory or inhibitory function. The generation of neurotransmitter receptors is controlled by distinct activity-regulated gene expression programs including cell type-specific transcription factors and downstream effectors, such as growth factors (Hua &amp; Smith, 2004; B. Lu et al., 2009; L. Nguyen et al., 2001). For example, AMPA-type glutamate receptors (AMPAR) are composed of four subunits, which contain mutually exclusive exons, “flip” and “flop” (Sommer et al., 1990). Alternative splicing of AMPAR subunits in the hippocampus is regulated by neuronal activity and calcium influx, and can alter the kinetic properties of the receptors resulting in variable responses to input signals (Lambolez, Ropert, Perrais, Rossier, &amp; Hestrin, 1996; Penn, Balik, Wozny, Cais, &amp; Greger, 2012; Tanaka, Grooms, Bennett, &amp; Zukin, 2000).

2.2 Neuronal Circuit Formation &amp; Maintenance

2.2.1 Neuronal Migration

The adult human central nervous system (CNS) contains approximately 86 billion neurons and over 160 trillion synapses (Herculano-Houzel, 2009; Silbereis, Pochareddy, Zhu, Li, &amp; Sestan, 2016; Tang, Nyengaard, De Groot, &amp; Gundersen, 2001). It is estimated that the number of synapses per neuron in the CNS is between 7,200 and 80,000 (DeFelipe, Alonso-Nanclares, &amp; Arellano, 2002; Huttenlocher, 1979; Pakkenberg &amp; Gundersen, 1997; Silbereis et al., 2016; Tang et al., 2001). How these neurons are spatially organized in the nervous system throughout development and how synapses are established is an area of intense investigation. Neuroepithelial cells that line the central cavity of the neural tube form the ventricular zone (VZ) and subventricular zone (SVZ) to serve as pools of progenitors for all neurons of the CNS. In the brain, these neuroepithelial cells are called radial glia, which undergo asymmetric division to maintain the progenitor pool and produce immature migrating neurons. Radial glia extend fibers radially outward from the VZ and SVZ through the intermediate zone (IZ) to form the cortical plate and to serve as scaffolds for neuronal migration. Newly born neurons migrate along the radial glia forming the cortical layers in an inside-out order (Figure 1A, see Sidebar) (de Graaf-Peters &amp; Hadders-Algra, 2006; Silbereis et al., 2016). RNA binding proteins, such as NOVA and RBFOX family proteins, are implicated in regulating the mRNA processing changes that contribute to establishment of polarity and migration of immature neurons (Leggere et al., 2016; Yano, Hayakawa-Yano, Mele, &amp; Darnell, 2010; Conboy, 2016). For example, knockout of Nova1/2 delays the migration of immature neurons in the spinal cord via disruption of Netrin-Dcc signaling (Leggere et al., 2016). Furthermore, migration of Purkinje neurons in the cerebellum of Nova2 knockout mice was inhibited via disruption of Reelin-Dab1 signalling (Yano, Hayakawa-Yano, Mele, &amp; Darnell, 2010).

2.2.2 Synaptogenesis

Neurons are functionally mature following dendritic and axonal outgrowth, and the formation of synapses. Cortical neurons vary by layer in key features, such as dendritic spine density and arborization, and axon length (Silbereis et al., 2016). Spine projections that develop from the cell body form the basal dendrites while apical dendrites are found at the distal end of the axon. Axons arise from extensions of the growth cone, a complex cytoskeletal structure, guided by chemoattractants or chemorepellents in the cerebrospinal fluid (de Graaf-Peters &amp; Hadders-Algra, 2006; Guérout et al., 2014). Synaptogenesis occurs between the apical dendrites of one neuron and the basal dendrites of another (Figure 1B). The specificity of these synaptic connections is based on cell surface markers (e.g. neurexins, neuroligins, and protocadherins), locally secreted molecules (e.g. semaphorins and WNT glycoproteins), and neuronal activity (Figure 1C) (Heckman &amp; Doe, 2021; Y. Pan &amp; Monje, 2020; Silbereis et al., 2016). Trans-synaptic cell adhesion proteins, such as neurexins/neuroligins and protocadherins, promote the development of functional synapses via compatible cell-cell interactions (Heckman &amp; Doe, 2021; J. L. Lefebvre, Kostadinov, Chen, Maniatis, &amp; Sanes, 2012; B. Lu et al., 2009; Oku et al., 2020; Schreiner &amp; Weiner Joshua, 2010). These synaptic proteins are important for self/non-self discrimination and interact in specific combinations (e.g. heterophilic versus isoform-specific homophilic) to increase the diversity of synaptic contacts while maintaining the specificity of the neuronal circuit. Furthermore, locally secreted molecules, including semaphorins and WNT glycoproteins, act as signals to guide subcellular synapse specificity (Fiore &amp; Püschel, 2003; C.-W. He, Liao, &amp; Pan, 2018; Heckman &amp; Doe, 2021; Park &amp; Shen, 2012).

2.2.3 Synaptic plasticity and aging

Neuronal activity plays an important role in the assembly, refinement, and maintenance of neural circuits (Figure 1C) (Citri &amp; Malenka, 2008; de Graaf-Peters &amp; Hadders-Algra, 2006; Heckman &amp; Doe, 2021; Ho, Lee, &amp; Martin, 2011; Katz &amp; Shatz, 1996; B. Lu et al., 2009; Y. Pan &amp; Monje, 2020). The primary function of the nervous system is to convey and process information from the environment, while maintaining a homeostatic level of activation (P. R. Lee &amp; Fields, 2020; Thalhammer, Jaudon, &amp; Cingolani, 2020). Activity-regulated gene expression programs are induced by membrane depolarization and encode downstream effectors and regulators of synaptogenesis. The continuous remodeling of synaptic biochemistry and morphology in response to stimuli is known as synaptic plasticity, the cellular basis for learning and memory (P. R. Lee &amp; Fields, 2020; Richter &amp; Klann, 2009). Rapid and robust changes in gene expression and mRNA translation contribute to the strengthening or weakening of synaptic connections (Donlin-Asp, Polisseni, Klimek, Heckel, &amp; Schuman, 2021; Kelleher, Govindarajan, &amp; Tonegawa, 2004; Mirisis &amp; Carew, 2019; Rajgor, Welle, &amp; Smith, 2021). Donlin-Asp and colleagues identified increased association of synaptic Camk2a and Psd95 transcripts with dendritic spines during two forms of plasticity - long-term potentiation and long-term depression - in hippocampal neurons, but this localization was uncoupled from local translation. These findings suggest that mRNA dynamics and protein synthesis are unique contributors to synaptic plasticity (Donlin-Asp, Polisseni, Klimek, Heckel, &amp; Schuman, 2021). In addition to synaptic plasticity, n eural circuits are also maintained via attenuation of apoptosis, which is initiated at neuron birth. Neuron-specific splicing of BAK, a pro-apoptotic BCL-2 family gene, via PTBP1 downregulation leads to retention of a poison microexon resulting in non-productive translation and impaired apoptotic capacity (Lin Lin, Zhang, Stoilov, Chen, &amp; Zheng, 2020; Y.-F. Sun, Yu, Saarma, Timmusk, &amp; Arumäe, 2001).

Changes in gene expression related to aging have also provided insight into changes in memory and cognition (Colantuoni et al., 2011; Loerch et al., 2008; T. Lu et al., 2004). During fetal and postnatal development, genes associated with synapse development (e.g. GABRA1/2, CHRNG, and KCNMA1) and energy metabolism (e.g. GSS, GFPT1, and AACS) rise to meet the demands of the developing brain and processing of novel stimuli, however, these genes reverse their expression during aging (Colantuoni et al., 2011; T. Lu et al., 2004; Somel et al., 2010). While neurons and synapses are not distinctly lost during aging, the genetic programs that control synaptic plasticity, such as synaptic vesicular transport (e.g. Sortilin, DNCH1, and CLTB) and ion channel homeostasis (e.g. CACNB2, GAD1, and KCNJ9), are greatly reduced (Colantuoni et al., 2011; Loerch et al., 2008; T. Lu et al., 2004; Somel et al., 2010). Additionally, aging and degenerative neurons exhibit unique patterns of autophagy dysregulation, mediated by changes in proteasomal and lysosomal function (Ding, Dimayuga, Markesbery, &amp; Keller, 2004; Jiang Cecilia, Tsien Joe, Schultz Peter, &amp; Hu, 2001; Lipinski Marta et al., 2010). Furthermore, reduced expression of genes associated with anabolic capacity, including energy production (e.g. NDUFA7/A11/S4, ATP6V0A1, and PDHB) and protein synthesis/transport (e.g. EIF2B3/4E/4G3/5, SHMT1, and TRIM3), were also observed (Berchtold et al., 2008). These reductions in neuronally-relevant gene programs are accompanied by increased cellular stress response programs, including DNA damage repair, inflammation, and antioxidant defense demonstrated by upregulation of HSPA2, HIF1α, and TNF-α (Berchtold et al., 2008; T. Lu et al., 2004; Stegeman &amp; Weake, 2017; Tollervey et al., 2011). Together, these findings suggest that decreased efficiency of genome maintenance may increase the susceptibility of highly transcriptionally active loci to DNA damage by oxidation and contribute to the loss of synaptic plasticity, cognition, and memory in the aging brain (Colantuoni et al., 2011; Loerch et al., 2008; T. Lu et al., 2004; Mecocci et al., 1993; Nunomura et al., 2012; Somel et al., 2010).

Sidebar: Key mRNA processing events in neuronal development

Neuronal genes undergo alternative processing to guide specific changes in development, including establishing polarity, migration, and synaptogenesis. The majority of these events arise from alternative splicing regulated by neuronal RBP families, such as NOVA1/2, PTBP1/2, and RBFOX1/2/3 (Su, D, &amp; Tarn, 2018). The following alternative splicing events have been identified as key processing changes related to specific neuronal functions.

Establishment of polarity (Figure 1A) Rho family GTPase, CDC42 (CDC42) – stable co-expression of CDC42 splice isoforms, derived from mutually exclusive exons 6 and 7, is regulated by PTBP1/2 and promotes axonogenesis (Yap et al., 2016). Furthermore, these splice isoforms alter the 3’ UTR, resulting in differentially localized transcripts in the soma or the dendrites (Mattioli et al., 2019). Cytoskeleton proteins (e.g. ADD1, ANK2, ANK3) - alternative splicing of cytoskeleton genes mediated by RBFOX and ELAVL family RBPs regulates protein domain interactions and subcellular localization to establish polarity and promote axonogenesis (Jacko et al., 2018; Ogawa, Yamaguchi, Yano, Uchiyama, &amp; Okano, 2018).

Neuronal migration (Figure 1A) Disabled-1 (DAB1) - alternative inclusion of multiple exons in DAB1 via NOVA2 association regulates tyrosine motifs important for downstream signalling and neuronal migration (Su et al., 2018; Yano, Hayakawa-Yano, Mele, &amp; Darnell, 2010; Bin Zhang et al., 2018).

Deleted in Colorectal Cancer (DCC) - alternative inclusion of a single exon in DCC via NOVA2 interaction dictates the presence of an extracellular domain important for axon guidance and interneuron migration in the spinal cord (Leggere et al., 2016; Saito et al., 2016; Su et al., 2018).

Microtubule dynamics (e.g. CLASP1/2, KIF21A) - mutually exclusive exons and exon exclusion events regulate the structure of microtubule-associated proteins which are important for restructuring the cytoskeleton during neuronal migration (Desai, Velo, Yamada, Overman, &amp; Engle, 2012; H. Lee et al., 2004; van der Vaart et al., 2013).

Synaptogenesis (Figure 1B) Synaptosomal Protein-25 (SNAP25) - alternative exon inclusion in SNAP25 regulated by RBFOX1 alters the composition of the SNARE complex, responsible for neuronal membrane trafficking, impacting membrane fusion dynamics and leading to altered synaptic transmission via neurotransmitter release (Bark et al., 2004; Gehman et al., 2011; Nagy et al., 2005; Su et al., 2018).

Post-Synaptic Density Protein-95 (PSD-95; DLG4) - alternative exon inclusion in DLG4 regulated by PTBP1/2 alters NMD-mediated repression of PSD-95, controlling synaptic protein scaffold assembly and regulating synaptic plasticity (Q. Li et al., 2014; Su et al., 2018; X. Zhang et al., 2016; S. Zheng et al., 2012).

3. MRNA ISOFORM DIVERSITY WITHIN AND BETWEEN NEURONAL SUBTYPES

Over 75% of human genes are subject to co- or post-transcriptional mRNA processing by AS and/or APA (Hoque et al., 2013; Q. Pan et al., 2008; Reyes &amp; Huber, 2018; Shepard et al., 2011; Tian et al., 2005; E. T. Wang et al., 2008). Most cell types, including neurons, utilize AS and APA to establish mRNA isoform diversity and modulate various mRNA properties, including mRNA stability and subcellular localization (Barash et al., 2010; Berkovits &amp; Mayr, 2015; Blair et al., 2017; Braunschweig et al., 2014; Hoffman et al., 2016; Jangi et al., 2014; Ji &amp; Tian, 2009; Lewis et al., 2005; Lewis et al., 2003; W. Li et al., 2016; Majoros &amp; Ohler, 2007; Mattioli et al., 2019; Merkin et al., 2012; Minis et al., 2014; Nakahata &amp; Kawamoto, 2005; Nam et al., 2014; Paradies &amp; Steward, 1997; Sandberg et al., 2008; Schreiner et al., 2014; Spellman et al., 2007; Spies et al., 2013; Stark et al., 2005; Ushkaryov &amp; Südhof, 1993; J. K. Vuong et al., 2022; J. Wang et al., 2021; R. Wang et al., 2018; Xie et al., 2005; E. Yang et al., 2003; S. Zheng et al., 2012). Accurate regulation of gene expression is essential in neurons. As cell types with unique morphological and physiological phenotypes, neurons require precise balance of mRNA isoforms to maintain cellular identity and electrophysiological function. The neuronal heterogeneity of the central nervous system associated with location, morphology, and function implies multiple transcriptomic regulatory layers (i.e. gene expression, alternative splicing and alternative polyadenylation) are responsible for highly specific neural patterning and cell type specification throughout development (Furlanis et al., 2019; Guvenek &amp; Tian, 2018; Ha, Sterne-Weiler, Morris, Weatheritt, &amp; Blencowe, 2021).

3.1 Alternative Splicing

Alternative splicing encompasses regulated changes in the coding information of a transcript, including skipped exons, retained introns, alternative 5’ or 3’ splice sites, and alternative first or last exons (Figure 2) (E. T. Wang et al., 2008). Alternatively, regulated exons are the most abundant type of neuron-specific AS events (Ellis et al., 2012). The inclusion/exclusion of coding sequence can lead to altered protein domain structure, which in turn, can affect protein-protein interactions (Figure 3) (Buljan et al., 2012). During neurodevelopment, highly conserved, switch-like AS at microexons (3–15 nucleotides in length) modulates the interaction domains of proteins involved in neurogenesis, including signalling pathways and cytoskeleton organization (M. Irimia et al., 2014). Inclusion of a 6 nucleotide microexon in the transcriptional coregulator Apbb1, which adds two charged residues to the PTB1 domain required for its interaction with the chromatin modifying enzyme Kat5, resulted in enhanced interaction by extending the binding interface. Genes with neuron-specific splicing are often enriched in neuronal functions, such as neurotransmitter receptors, ion channels, adhesion, and scaffold proteins (Ule et al., 2005). Despite sharing similar gene expression programs, neuronal subclasses can be distinguished by AS of synaptic proteins, such as Nrxn3, Nlgn2, Gria1/2, and Cacna1d/g (Furlanis et al., 2019). Cell type-specific splicing programs function to fundamentally shape synapse assembly and intrinsic neuronal properties, which can be organized into five categories: 1) adhesion complexes, 2) voltage-gated ion channels, 3) pre-synaptic release machinery, 4) post-synaptic neurotransmitter receptor complexes, and 5) scaffold proteins.

Protocadherins (PCDHs), also known as cadherin-related neuronal receptors, are a subfamily of cadherins that are important for defining neuronal cell types and regulating cell-cell recognition (Kohmura et al., 1998; Rubinstein et al., 2015). Furthermore, PCDHs serve as receptors of Reelin, an extracellular matrix protein involved in cell adhesion, and combine via trans homophillic interactions to establish neuronal networks in the developing cortex (D’Arcangelo et al., 1995; Senzaki, Ogawa, &amp; Yagi, 1999). Over 50 PCDH genes have been identified, organized into three tandem gene clusters – α, β, and γ (H. Sugino et al., 2000; Wu &amp; Maniatis, 1999; Wu et al., 2001). Within each cluster, PCDH genes contain a large, unique 5’ exon, encoding the variable extracellular domains, with smaller 3’ exons, encoding the identical intracellular domain (Wu &amp; Maniatis, 1999), and cell type-specific expression of PCDH isoforms is achieved through alternative transcription initiation and splicing of 5’ exons (Esumi et al., 2005; Hirano et al., 2012; Kaneko et al., 2006; Tasic et al., 2002; X. Wang, Su, &amp; Bradley, 2002). Interestingly, PCDH isoforms are differentially localized within neurons (Junghans et al., 2008; Kallenbach et al., 2003; Phillips et al., 2003) and play distinct roles in dendritic and axonal development and connectivity (W. V. Chen et al., 2017; Katori et al., 2017; Mountoufaris et al., 2017; Suo, Lu, Ying, Capecchi, &amp; Wu, 2012). For example, Junghans and colleagues demonstrated differential localization of Pcdhb16 and Pcdhb22 isoforms in retinal neurons in which Pcdhb16 was localized to the post-synapse and Pcdhb22 was less synapse-restricted (Junghans et al., 2008). Additionally, Kallenbach and colleagues showed subcellular localization of Pcdh-γ was dynamically regulated during spinal neuron development; early in differentiation, Pcdh-γ is broadly localized to both dendritic and axonal growth cones, but expression is progressively restricted to the somatodendritic compartment as the neurons mature (Kallenbach et al., 2003).

Neurexins (NRXNs) are a family of presynaptic cell-adhesion molecules – NRXN1, 2, and 3 – crucial for defining synaptic connectivity through differential interactions with neuroligins at the post-synaptic membrane. NRXN genes undergo alternative transcription initiation to produce three distinct isoform subclasses – α, β, and γ – which are extensively alternatively spliced to generate over 1,300 unique isoforms that are neuronal subtype specific, and neurexin splicing profiles have been shown to correlate with marker genes of neurodevelopmental origin. (Fuccillo et al., 2015; Lukacsovich et al., 2019; Schreiner et al., 2014; Treutlein, Gokce, Quake, &amp; Südhof, 2014; Ushkaryov &amp; Südhof, 1993). For example, a major splice isoform switch at alternatively spliced segment 4 in all three NRXN isoform subclasses distinguishes excitatory and inhibitory neuronal populations in the hippocampus (T.-M. Nguyen et al., 2016). Regulation of NRXN splicing is controlled by neuronal RBPs, including the general neuronal splicing regulator PTBP2 (Resnick, Segall, G, Lupowitz, &amp; Zisapel, 2008) and neuronal subtype-specific STAR family proteins (Ehrmann et al., 2016; Iijima, Iijima, Witte, &amp; Scheiffele, 2014; Iijima et al., 2011; Traunmüller, Bornmann, &amp; Scheiffele, 2014; Traunmüller, Gomez Andrea, Nguyen, &amp; Scheiffele, 2016).

3.2 Alternative Polyadenylation

Alternative polyadenylation refers to regulated changes in the 3’ UTR of an mRNA molecule, most often observed as tandem 3’ UTRs, in which multiple polyadenylation signals are available within a single transcript for cleavage and polyadenylation (Figure 2) (E. T. Wang et al., 2008). However, some AS events can coincide with APA events, namely, alternative last exons or splicing that retains a functional intronic or coding sequence polyadenylation signal. Furthermore, U1 snRNP, a spliceosome component, has been shown to dose-dependently block polyadenylation at proximal or upstream polyA sites in a process called telescripting, which serves to maintain the transcriptional integrity of differentiated cell types (Berg et al., 2012; Kaida et al., 2010). General lengthening of mRNA 3’ UTRs is associated with differentiation and development, with neurons expressing the longest 3’ UTRs (Agarwal et al., 2021; Guvenek &amp; Tian, 2018; Hilgers et al., 2011; Miura et al., 2013). Over 70% of neuron-enriched genes express multiple 3’ UTR isoforms (Tushev et al., 2018), each containing an array of regulatory information, including miRNA binding sites, sites of RBP recognition, and molecular ‘barcodes’ which determine subcellular localization (Figure 3). In addition to its association with development and cell type specification, APA is also induced by neuronal activity (Berg et al., 2012; Flavell et al., 2008; Fontes et al., 2017; Lau et al., 2010; Tushev et al., 2018). Long-term potentiation of neurons is coupled with 3’ UTR shortening and activation of intronic polyadenylation sites, contributing to neuronal plasticity (Tushev et al., 2018). Shortening of 3’ UTRs in response to neuronal activation often results in truncations of the coding sequence, leading to alternative protein function, or removal of length-dependent inhibitory mechanisms, allowing for rapid and robust mRNA translation (Flavell et al., 2008; Lau et al., 2010).

3.2.1 miRNA-mediated regulation &amp; translation efficiency

miRNAs bind to 3’ UTRs and post-transcriptionally regulate gene expression via transcript degradation or inefficient translation (Filipowicz, Bhattacharyya, &amp; Sonenberg, 2008; Hoffman et al., 2016; Majoros &amp; Ohler, 2007). Two-thirds of genes targeted by miRNAs have alternative 3’ UTRs and 40% of these binding sites are located in alternative 3’ UTR segments (Majoros &amp; Ohler, 2007). While miRNA expression is often ubiquitous, the mRNA targets of miRNA-mediated repression are often alternatively 3’ end processed to modulate the presence of the miRNA binding site within the 3’ UTR, suggesting regulation of gene expression by miRNAs is cell type-specific (Ji &amp; Tian, 2009; Lewis et al., 2005; Lianoglou et al., 2013; Nam et al., 2014; J. Wang et al., 2021). For example, the binding site for miRNA miR-33–3p is present in alternative 3’ UTRs of Camk2a expressed in mammalian hippocampal neurons of the CA1 region (Tushev et al., 2018). Futhermore, n eurons express long 3’ UTRs, leading to ample opportunity for RBP and miRNA binding to have a strong effect on mRNA translation efficiency (Blair et al., 2017; Miura et al., 2013). For example, MECP2, a global regulator of transcription required for proper brain development, is post-transcriptionally regulated during neurodevelopment (R. Li et al., 2016; Rodrigues et al., 2016). In differentiated cortical neurons, the long 3’ UTR of MECP2 (MECP2-L) shows enhanced stability due to the absence of pluripotent cell-specific miRNAs (Rodrigues et al., 2016). Furthermore, MECP2-L is translationally silenced in stem cells by the binding of TIA1, and translationally activated in neurons by the binding of ELAVL3/HuC.

3.2.2 Subcellular localization &amp; isoform-specific function

Targeted mRNA subcellular localization is utilized by neurons as a means for distributing transcripts to specific cellular compartments for rapid local translation (Kleiman, Banker, &amp; Steward, 1990; Paradies &amp; Steward, 1997). The molecular ‘barcodes’ that direct a transcript to a specific cellular compartment are typically located within the 3’ UTR, and therefore, can be affected by alternative 3’ end processing (An et al., 2008; Berkovits &amp; Mayr, 2015; Mattioli et al., 2019; Minis et al., 2014; Taliaferro et al., 2016; Tushev et al., 2018). In neurons, transcripts with long 3’ UTRs often localize to the neurites, including BDNF and CAMK2A, however localized transcripts, in general, have longer 3’ UTRs than non-localized transcripts (Taliaferro et al., 2016; Tushev et al., 2018). Furthermore, localized neuronal transcripts show enrichment for temporal or activity-regulated cell type-specific functions, such as synaptic maintenance and cytoskeletal organization (Cajigas et al., 2012; Gumy et al., 2011). For example, brain-derived neurotrophic factor (BDNF) transcripts contain alternative 3’ UTRs that dictate subcellular localization and isoform-specific function (An et al., 2008; Lau et al., 2010). The short 3’ UTR of BDNF is localized to the soma and is responsible for maintaining basal protein levels, while the long 3’ UTR is localized to the neurites for activity-dependent rapid initiation of translation. Subcellular localization is also often associated with location-specific function. In particular, CDC42, important for establishing neuronal polarity via cytoskeleton reorganization, is differentially localized to the soma and neurites to participate in local axonogenesis and dendritic spine development, and this isoform-specific function is mediated by alternative 3’ UTRs (C. Chen, Wirth, &amp; Ponimaskin, 2012; Mattioli et al., 2019; Yap et al., 2016).

3.3 RNA binding proteins

RNA binding proteins are integral to the regulation of alternative mRNA processing. Sequence motifs present within nascent RNA are recognized by various RBP family proteins, such as PTBP, FOX, NOVA, and MNBL, which are crucial for tissue- and temporally-regulated alternative mRNA processing, especially within neurons (Weyn-Vanhentenryck et al., 2018). Moreover, RBPs with splicing functions often regulate their own expression, and that of other RBPs, through usage of poison exons (Boutz et al., 2007; Dredge, Stefani, Engelhard, &amp; Darnell, 2005; Jangi et al., 2014; Spellman et al., 2007; C. Zhang et al., 2008), however, for some splicing modulators, autoregulation is achieved through the generation of a dominant negative isoform (Damianov &amp; Black, 2010). Neuron-specific RBPs operate in a position-dependent manner (Licatalosi et al., 2008; Llorian et al., 2010; Xue et al., 2009) and the targets of these RBPs are often linked to key neuronal functions, including synapse assembly and axon guidance (Flavell et al., 2008; Jelen, Ule, Živin, &amp; Darnell, 2007; Traunmüller et al., 2014; Ule et al., 2005; C. K. Vuong, Black, &amp; Zheng, 2016; S. Zheng, 2020).

3.3.1 NOVA Family RNA Binding Proteins

The NOVA family of RBPs (NOVA1/2) were the first tissue-specific splicing factors found to be restricted to neurons (Ronald J. Buckanovich, Posner, &amp; Darnell, 1993; R. J. Buckanovich, Yang, &amp; Darnell, 1996; Y. Y. L. Yang, Yin, &amp; Darnell, 1998). The association of NOVA proteins to RNA is sequence-specific, preferentially binding to YCAY-rich elements near splice sites, and leads to a location-dependent effect on splicing (i.e. binding of NOVA within an alternative exon leads to repression of exon inclusion, whereas binding of NOVA within the intron downstream of the regulated exon results in enhanced inclusion) (Dredge et al., 2005; Jensen et al., 2000; Licatalosi et al., 2008; Ule et al., 2006). NOVA proteins have also been implicated in the regulation of APA in the brain, promoting the usage of long 3’ UTRs for dozens of genes, including Cugbp2 and Slc8a1 (Hwang et al., 2017; Licatalosi et al., 2008). The targets of NOVA-mediated splicing and polyadenylation are enriched in core neuronal functions, including synaptic adhesion, ion channels, and cytoskeletal proteins (Jelen et al., 2007; Ule et al., 2005; S. Zheng, 2020). For example, NOVA2 binding inhibits the inclusion of DAB1 exons 7b/c, associated with dysregulated Reelin signalling, which is important for proper neuronal migration in the mammalian brain (Yano et al., 2010).

3.3.2 PTBP Family RNA Binding Proteins

The PTBP family of RBPs (PTBP1/2) are developmentally-regulated splicing factors that bind to polypyrimidine tracts in RNA (Licatalosi et al., 2012; Su et al., 2018). PTBP1 is widely expressed and displays promiscuous functions in mRNA stability, transport, translation, and pre-mRNA processing (Sawicka, Bushell, Spriggs, &amp; Willis, 2008). In contrast, PTBP2, or nPTBP, expression is restricted to neuronal cell lineages (Ashiya &amp; Grabowski, 1997; Lilleväli, Kulla, &amp; Örd, 2001) and regulates splicing of neuron-specific exons, particularly in genes with functions in axonogenesis (e.g. exons 22 and 29 of Kif21a and exon 9 of Clip2) (Q. Li et al., 2014; M. Zhang et al., 2019). PTBP2 is regulated by the near-ubiquitous PTBP1 via inclusion of a poison exon, which induces NMD (Boutz et al., 2007; Spellman et al., 2007), while neuron-specific expression of microRNA miR-124 directly targets PTBP1 mRNA to promote neuronal development (Makeyev, Zhang, Carrasco, &amp; Maniatis, 2007). The effect of PTBP family proteins on splicing is location-dependent; binding of PTBP1/2 upstream of or within an alternative exon results in repression of inclusion, and binding of PTBP1 downstream of an alternative exon results in activation of inclusion (Licatalosi 2012, Llorian 2010) Furthermore, PTBP1 and PTBP2 regulate a distinct but partially overlapping set of exons, although genes with PTBP2-mediated splicing are enriched in cytoskeletal rearrangement and vesicular transport important for axonogenesis and synaptic transmission (e.g. Dst, Ktn1, Mprip, Ntrk2, and Grin1) (Boutz et al., 2007; Flavell et al., 2008; Licatalosi et al., 2012; J. K. Vuong et al., 2016). For example, PTBP2 inhibits the inclusion of exons 15 and 16 in SHOOTIN1 (SHTN1) transcripts which triggers a developmental isoform switch from SHTN1-long to SHTN1-short to promote axonogenesis (M. Zhang et al., 2019).

3.3.3 ELAVL/Hu Family RNA Binding proteins

The neuron-specific members of the ELAVL/Hu (ELAVL2–4/HuB-D) family (hereby referred to as nELAVL) play important roles in neuronal development. Individual nELAVL proteins are expressed at distinct time points during neurogenesis to suppress progenitor cell proliferation and guide neural progenitors to a neuronal cell fate (Akamatsu et al., 1999; Okano &amp; Darnell, 1997). Specifically, Elavl2 expression is high in early stages of neurodevelopment within the ventricular zone, extending through the intermediate zone, and decreases in neurons of the cortical plate (Okano &amp; Darnell, 1997). In contrast, Elavl3 is absent in immature neurons of the ventricular and intermediate zones but is highly expressed in neurons of the cortical plate. Elavl4 expression is mainly restricted to the immature neurons of the intermediate zone, and decreases as neurons reach the cortical plate. Binding of nELAVL proteins to RNA is sequence-specific, preferentially associating with GU-rich sequences at exon-intron junctions, and the effect on splicing is location-dependent (i.e. binding of nELAVL to the intron downstream of an alternative exon promotes exon inclusion, while binding within the alternative exon represses exon inclusion) (Ince-Dunn et al., 2012). Binding of nELAVL proteins to GU-rich sequences within the 3’ UTR is also involved in the maintenance of mRNA steady state levels by enhancing mRNA stability (Ince-Dunn et al., 2012; Mukherjee et al., 2011; Pascale et al., 2005). Furthermore, although specific binding of nELAVL proteins to the ubiquitously-expressed ELAVL1/HuR to promote expression of a long 3’ UTR and a less stable transcript has been demonstrated, recent bioinformatic analyses have suggested that nELAVL proteins may promote global usage of distal polyA sites during neuronal differentiation by binding to U-rich sequences (S. Lee et al., 2021; Mansfield &amp; Keene, 2012). The targets of nELAVL-mediated splicing are enriched in protein complexes and cytoskeletal dynamics at the synapse and axon, while the transcripts with regulated steady-state levels are enriched for amino acid and sugar biosynthetic pathways (Berto, Usui, Konopka, &amp; Fogel, 2016; Ince-Dunn et al., 2012; S. Lee et al., 2021; Ogawa et al., 2018). For example, ELAVL3/HuC is required for the splicing of AnkyrinG (ANK3) at exon 34, of which in clusion of this exon is reduced with neuronal maturity and the shorter isoform contributes to cytoskeletal rearrangements required for establishing the axon initial segment during neuronal polarization (Ogawa et al., 2018).

4. CONSEQUENCES OF ALTERED MRNA ISOFORM BALANCE

4.1 Neurological diseases with complex genetic and idiopathic etiologies (Table 1)

4.1.1 Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease mainly affecting the upper and lower motor neurons in the spinal cord, although ALS is often associated with frontotemporal dementia (FTLD). Roughly 85% of ALS cases are sporadic, with no known genetic etiology, and the remaining 15% of cases have been attributed to mutations in over 30 genes (Siddique &amp; Siddique, 2001 [Updated 2021]). The four most common variants in familial ALS are found in C9orf72, SOD1, FUS, and TARDBP. Of these commonly mutated genes, TARDBP, encodes TDP-43, a known regulator of RNA processing and metabolism (Birsa, Bentham, &amp; Fratta, 2020; Lagier-Tourenne, Polymenidou, &amp; Cleveland, 2010; Ou, Wu, Harrich, García-Martínez, &amp; Gaynor, 1995; Ratti &amp; Buratti, 2016) and mutations in TDP-43 cause ALS type 10 (OMIM # 612069; (Gitcho et al., 2008; Kabashi et al., 2008; Sreedharan et al., 2008; Van Deerlin et al., 2008)). Characterization of TDP-43 mutations in ALS has revealed loss-of-function properties, such as dysregulation of cassette exon inclusion/exclusion (Polymenidou et al., 2011; Tollervey, Curk, et al., 2011), and toxic gain-of-function properties, such as sequestration of RBPs and impaired nuclear import/export (Chou et al., 2018; Liu-Yesucevitz et al., 2010; Neumann et al., 2006). Specifically, pathological TDP-43 aggregates contain several members of the nucleoporin [NUP], importin [IPO], and exportin [XPO] protein families resulting in nuclear retention of polyadenylated mRNAs and accumulation of nuclear proteins in the cytoplasm, including Ptbp1, Pabpc4, and Cstf2. Recently, TDP-43 depletion was found to result in misprocessing of an intronic polyadenylation site within Stathmin-2 (STMN2), leading to reduced expression of STMN2, a mediator of axonal outgrowth and regeneration (Guerra San Juan et al., 2022; Klim et al., 2019; Melamed et al., 2019). Usage of this cryptic intronic polyadenylation site in ALS patient-derived cell lines caused premature termination of STMN2 and is predicted to generate a severely truncated protein (Melamed et al. 2019). Axonal regenerative capacity of the ALS cell lines was restored by exogenous expression of full length STMN2 mRNA (Melamed et al., 2019) or by post-translational stabilization of STMN2 protein (Klim et al., 2019). Considering the involvement of other ALS-related genes (e.g. hnRNPA1, hnRNPA2B1, and TIA1) in various aspects of RNA biogenesis (e.g. splicing, miRNA-mediated regulation, and cellular stress response), mRNA misprocessing has emerged as a major contributor to ALS pathogenesis (Butti &amp; Patten, 2019, Clarke 2021, Forch 2000, Alarcon 2015).

4.1.2 Alzheimer’s Disease

Alzheimer’s Disease (AD) is the most common late-onset neurodegenerative disease. AD is characterized by slow- progressing cognitive impairments, such as loss of memory, speech, attention, and executive function (Albert et al., 2011; Biamonti et al., 2021; Rybak-Wolf &amp; Plass, 2021). The pathological features of AD include extracellular β-amyloid plaques and intracellular neurofibrillary tangles containing hyperphosphorylated Tau in the brain (Ittner &amp; Götz, 2011). The majority of Alzheimer’s disease cases are sporadic, and non-genetic factors of environment and lifestyle are predicted to significantly contribute to disease risk (Gatz et al., 2006). None-the-less, mRNA splicing defects are associated with disease in both inherited and sporadic AD cases (Biamonti et al., 2021; Patel et al., 2019; Rybak-Wolf &amp; Plass, 2021). For example, aberrant splicing caused by a splice donor mutation within intron 4 of PSEN1, encoding a component of the γ-secretase complex involved in the cleavage of amyloid precursor protein, produces two truncated transcripts and one transcript with a pathological insertion of threonine between amino acid 113 and 114 (De Jonghe et al., 1999). The transcript with the encoded amino acid insertion is associated with increased secretion of Aβ42 and early-onset AD. Furthermore, reduced expression of RBPs, such as PTBP2, NOVA1 and NUDT21, in aged neurons (and exacerbated in AD neurons) results in altered splicing of neuronal genes (e.g. GABBR1, KCNMA1, NRXN3, and SNAP25), leading to defects in neuron-related processes, such as synaptic transmission, that may contribute to AD progression (Adusumalli, Ngian, Lin, Benoukraf, &amp; Ong, 2019; Han et al., 2019; Tollervey, Wang, et al., 2011). Indeed, increased expression of RBPs, such as TDP-43, EWSR1, and CLP1, have been associated with splicing and 3’ end processing defects within a subset of genes in AD neurons, and correlate with disease pathology and cognitive impairment, respectively (Barbash et al., 2017; E. C. B. Johnson et al., 2018; Marques-Coelho et al., 2021; Raj et al., 2018).

4.1.3 Parkinson’s Disease

Parkinson’s Disease (PD) is a progressive neurodegenerative disease characterized by asymmetric resting tremor, bradykinesia, and non-motor features, including anosmia, autonomic dysfunction, and cognitive decline (Simon, Tanner, &amp; Brundin, 2020). The pathological symptoms of PD include loss of dopaminergic neurons in the substantia nigra and cytoplasmic inclusions containing alpha-synuclein aggregates called Lewy bodies. Additionally, neurons in the substantia nigra exhibit impaired calcium homeostasis, lysosomal and mitochondrial dysfunction, and metabolic stress (Duda, Pötschke, &amp; Liss, 2016). The majority of PD cases are sporadic, suggesting lifestyle and environmental factors affect PD risk (Goldman et al., 2019). Genes causative for familial PD, such as LRRK2, have been associated with increased mRNA translation via repression of miRNA activity and positive regulation of ribosomal protein transcripts. Recently, specific mRNA processing changes in PD-associated genes, LRPPRC and PINK1, have linked mRNA processing defects to PD pathology (Gaweda-Walerych, Mohagheghi, Zekanowski, &amp; Buratti, 2016; Martin, 2016; Simon et al., 2020). For example, alternative 3’ end processing of SCNA, encoding the pre-synaptic neuronal protein α-synuclein, has been associated with increased protein expression and mislocalization, away from synaptic terminals (Blažeković, Jerčić, &amp; Borovečki, 2021; Rhinn et al., 2012). Additionally, disease-specific RNA and 3’ end expression profiles in sporadic PD cases suggest transcriptomic alterations are a hallmark of disease pathology (LaForce et al., 2022; Schulze et al., 2018).

4.1.4 Autism Spectrum Disorder &amp; Intellectual Disability

Autism Spectrum Disorder (Arnadottir et al., 2022) and Intellectual Disability (ID) describe a heterogenous group of neurodevelopmental disorders with many overlapping and unique clinical phenotypes (Bishop, Gahagan, &amp; Lord, 2007; Moss &amp; Howlin, 2009; Thurm, Farmer, Salzman, Lord, &amp; Bishop, 2019). For some cases of ASD and ID, the genetic etiology is known – e.g. Fragile X, Rett, and Angelman syndromes – however, the majority of cases arise from complex genetic interactions (Abrahams &amp; Geschwind, 2008; Moss &amp; Howlin, 2009). Recent advances in RNA sequencing technologies have highlighted the contributions of transcriptional and translational control to ASD and ID phenotypes (Chau et al., 2021; Joo &amp; Benavides, 2021; Quesnel-Vallières, Weatheritt, Cordes, &amp; Blencowe, 2019; Weil, Piton, Lessel, &amp; Standart, 2020). ASD and ID have been associated with defects in splicing (Akawi et al., 2016; T. Chen et al., 2019; Fliedner et al., 2020; M. Irimia et al., 2014; Poirier et al., 2017; Urreizti et al., 2020; Q. Wang, Moore, Adelmant, Marto, &amp; Silver, 2013), 3’ end formation (Arnadottir et al., 2022; Gennarino et al., 2015; Grozdanov et al., 2020), regulation of RBPs (Y. Lee et al., 2020; L. S. Nguyen et al., 2012; Reichert et al., 2020), and mRNA translation (Beaulieu et al., 2013; Kumar et al., 2015). For example, synaptic genes, CASK and RELN, and cytoskeletal genes, ANK2 and CLASP2, contain microexons that are dysregulated in ASD brains (Irimia et al., 2014). Furthermore, increased copy numbers of NUDT21, encoding CFIm25, is associated with ID syndrome and increased usage of a distal polyadenylation site of MECP2, which is inefficiently translated and results in reduced protein expression (Gennarino et al., 2015). Neuronal activity is highly correlated with the key cellular pathways frequently altered in ASD and ID – WNT signaling, neuronal development and circuit formation, synaptic activity, and local mRNA translation (Joo &amp; Benavides, 2021; Purcell, Jeon, Zimmerman, Blue, &amp; Pevsner, 2001; Quesnel-Vallières et al., 2019; Rubenstein &amp; Merzenich, 2003; Takarae &amp; Sweeney, 2017). Although it remains unclear if altered neuronal activity is a cause or consequence of dysregulated neuronal gene expression, an overall disruption of neuronal homeostasis appears to underlie ASD and ID phenotypes.

4.1.5 Cancers of the Nervous System

Nervous system tumors are a heterogenous group of diseases characterized by abnormal cell growth and metabolic reprogramming affecting regions of the brain and spinal cord (Bielli, Pagliarini, Pieraccioli, Caggiano, &amp; Sette, 2020; Y. Zheng et al., 2021). Aberrant mRNA processing is an established hallmark of many cancers (Frankiw, Baltimore, &amp; Li, 2019; Singh et al., 2009). Systematic profiling of the glioblastoma multiforme transcriptome identified over 45,000 alternative splicing events in ~10,000 genes with the goal of identifying biomarker events to improve prognosis and guide clinical treatment (X. Chen et al., 2019; Botao Zhang, Wu, Cheng, &amp; Li, 2021). Another study found aberrant splicing of tumor suppressor annexin A7 (ANXA7) in glioblastoma due to loss of miRNA, miR-124, responsible for suppressing expression of PTBP1 in neural tissues (Ferrarese et al., 2014). In addition to alterations in splicing, misprocessing of mRNA 3’ ends can also drive pathogenicity or serve as a prognostic biomarker (Masamha et al., 2014; Mayr &amp; Bartel, 2009; Ogorodnikov et al., 2018). In glioblastoma, CFIm25 expression is reduced, leading to global 3’ UTR lengthening and enhanced cell proliferation (Masamha et al., 2014). Similarly, PCF11 expression in neuroblastoma was shown to correlate with a cancer stem cell phenotype by driving highly proliferative, embryonic programs (Ogorodnikov et al., 2018). Thus, although mRNA misprocessing is typically secondary to pathogenic mutations in nervous system cancers, some changes appear unique to specific cancer subtypes, and can be used as prognostic biomarkers and therapeutic targets.

4.2 Monogenic neurological diseases (Table 1)

4.2.1 Huntington Disease

Huntington Disease (HD, OMIM #143100) is an adult-onset neurodegenerative disorder characterized by chorea, dystonia, incoordination, dementia, and behavioral difficulties, which can be preceded by up to a decade of mild psychotic and behavioral symptoms. HD is caused by a CAG-repeat expansion in the Huntingtin gene (Maslon et al.) – unaffected individuals typically have approximately 9–35 repeats, whereas affected individuals typically have ≥ 40 repeats – and the number of repeats correlates with age of onset of symptoms (Andrew et al., 1993; Aronin et al., 1995; Brinkman, Mezei, Theilmann, Almqvist, &amp; Hayden, 1997; Duyao et al., 1993; Nance &amp; Myers, 2001; Snell et al., 1993; Trottier, Biancalana, &amp; Mandel, 1994). HTT mRNA is alternatively processed via alternative inclusion of exons 28 and 29 (Hughes et al., 2014; Mort et al., 2015; Ruzo et al., 2015) and variable 3’ UTR length (B. Lin et al., 1993; Romo, Ashar-Patel, Pfister, &amp; Aronin, 2017). The functional consequences of HTT alternative splicing are unclear (skipping of exon 29 is in-frame, while skipping of exon 28 is out-of-frame, resulting in a premature termination codon within exon 29), but variation in 3’ UTR length is associated with cell type-specific expression (Hughes, B. Lin et al., 1993; Romo et al., 2017), and the longest HTT isoform is most abundant in the brain. Protein fragments produced by proteolysis of mutant HTT localize to pathogenic intranuclear and cytoplasmic inclusions in neurons (DiFiglia et al., 1997; Lunkes et al., 2002). Similar to other repeat expansion disorders, mutant HTT sequesters RBPs, notably the MBNL1 splicing factor, within these nuclear inclusions (Mykowska, Sobczak, Wojciechowska, Kozlowski, &amp; Krzyzosiak, 2011), leading to a broad pattern of splicing defects (Becanovic et al., 2010; Lan Lin et al., 2016; Mykowska et al., 2011) and changes in 3’ UTR length (Romo et al., 2017) of the RBP targets.

4.2.2 Pontocerebellar Hypoplasia

Pontocerebellar Hypoplasia (PCH) is a heterogeneous group of pediatric neurodegenerative disorders frequently caused by mutations in proteins involved in RNA and protein metabolism (van Dijk, Baas, Barth, &amp; Poll-The, 2018). Over 20 subtypes of PCH have been described to date. Each subtype exhibits the classical features of cerebellar and brainstem atrophy, combined with unique phenotypes, such as cortical malformations and dysmorphic facial features (van Dijk et al., 2018). Mutations causing PCH are enriched in genes required for RNA metabolism and processing - two subtypes of PCH with mutations in mRNA processing proteins are described below.

PCH subtypes 1B (OMIM # 614678), 1C (OMIM # 616081), 1D (OMIM # 618065), and 1F (OMIM # 619304) are caused by mutations in subunits of the RNA exosome, EXOSC3, EXOSC8, EXOSC9, and EXOSC1, respectively. PCH1 patients exhibit progressive muscle weakening, microcephaly, hearing and vision impairment, impaired myelination, and motor neuron degeneration often leading to respiratory failure (Boczonadi et al., 2014; Burns et al., 2018; Donkervoort et al., 2017; Rudnik-Schöneborn et al., 2013; van Dijk et al., 2018; Wan et al., 2012). The RNA exosome is composed of a nine-subnunit core and an exoribonuclease (Q. Liu, Greimann, &amp; Lima, 2006; Mitchell, Petfalski, Shevchenko, Mann, &amp; Tollervey, 1997) and is involved in the turnover of inherently unstable mRNAs. Unstable mRNA molecules contain AU-elements (ARE) within the 3’ UTR, which are recognized by ARE-binding proteins, such as AUF1, TTP, and KSRP, and trafficked to the exosome via interactions with the DEVH box family of RNA helicases, such as SKI2W or MTR4 (C.-Y. Chen et al., 2001; Kilchert, Wittmann, &amp; Vasiljeva, 2016). Mutations in exosome subunits impair complex assembly by altering stoichiometric ratios or inhibiting protein-protein interactions with other subunits (Morton et al., 2018). Furthermore, mutation of exosome complex subunits caused increased levels of p53 transcript and protein stabilization, resulting in G2/M cell cycle arrest and increased cell death (Müller et al., 2020), likely contributing to the severe clinical phenotypes observed in PCH1 patients (Boczonadi et al., 2014; Burns et al., 2018; Donkervoort et al., 2017; Rudnik-Schöneborn et al., 2013; van Dijk et al., 2018; Wan et al., 2012).

PCH subtype 10 (PCH10, OMIM # 615803) is caused by homozygous p.R140H mutation in CLP1 (Karaca et al., 2014; Schaffer et al., 2014; Wafik, Taylor, Lester, Gibbons, &amp; Shears, 2018). PCH10 patients exhibit severe intellectual disability, progressive microcephaly, limb spasticity, refractory seizures, and progressive spinal motor neuron disease. CLP1 is a subunit of the CFIIm subcomplex of the CPA complex (de Vries et al., 2000), and promotes the expression of RBPs involved in mRNA 3’ end formation, specifically PCF11, CFIm68, CPSF100, and CstF64 (LaForce et al., 2022). The p.R140H variant disrupts the CFIIm subcomplex and also impairs the association of the CPSF and CstF subcomplexes with RNA polymerase II (LaForce et al., 2022; Schaffer et al., 2014). Recently, CLP1 was implicated in regulation of mRNA isoform diversity by repressing proximal polyadenylation sites, and this function is augmented by the PCH10-associated p.R140H variant (LaForce et al., 2022; Monaghan, Adamson, Kapur, Chuang, &amp; Ackerman, 2021). In PCH10 patient-derived motor neurons, mRNA 3’ UTR lengthening was correlated with long gene overexpression, including genes enriched in ion channel and synaptic functions, which likely promotes motor neuron differentiation and alters neuronal activity, potentially contributing to the neuropathy observed in PCH10 patients (Karaca et al., 2014; LaForce et al., 2022).

4.2.3 Rett Syndrome

Rett syndrome (RTT, OMIM #312750) is a neurodevelopmental disorder, almost exclusively affecting females, characterized by rapid loss of motor and language skills at 7–18 months, autism and dementia phenotypes, ataxia, epilepsy, and progressive microcephaly (Hagberg, Aicardi, Dias, &amp; Ramos, 1983). Mutations in MECP2, encoding methyl-CpG-binding protein 2, located on the X chromosome, account for over 95% of RTT cases (Amir et al., 1999; Moretti &amp; Zoghbi, 2006). Alternative splicing and polyadenylation of MECP2 produces 22 predicted and validated mRNA isoforms and protein products, but the functional roles of these isoforms remain unclear (Kriaucionis &amp; Bird, 2004; Mnatzakanian et al., 2004; Rodrigues et al., 2016). In the nervous system, MECP2 is most highly expressed in maturing glutamatergic neurons (B. Lu et al., 2009; Shahbazian, Antalffy, Armstrong, &amp; Zoghbi, 2002), and promotes/maintains RNA synthesis in neurons during maturation (Chahrour et al., 2008; Petazzi et al., 2013; Yasui et al., 2007; Yazdani et al., 2012). Additionally, MECP2 interacts with modulators of splicing, such as DHX9 and LEDGF, to regulate splicing of ion channel genes, including the flip/flop exons of Gria2 and other AMPAR genes (R. Li et al., 2016; Young et al., 2005). Loss of MECP2 expression in neurons results in overexpression of long genes, such as Dcc, Cntn4, and Dlgap2 (Gabel et al., 2015; Pacheco et al., 2017; K. Sugino et al., 2014), and aberrant splicing of ion channel genes (e.g. Kcnj2, Gabrd, and Scn1a) (Gabel 2015, Young et al., 2005), predicted to contribute to autism and epilepsy in RTT patients.

Conclusions &amp; Future Perspectives

Regulation of neuronal gene expression is a concerted effort of thousands of proteins. Neuron-specific genes are disproportionately long, and extensive alternative processing yields an abundance of mRNA isoforms (Gabel et al., 2015; King et al., 2013; Lerch et al., 2012; X. Liu et al., 2011; Miura et al., 2013; Schreiner et al., 2014; Takeuchi et al., 2018; Ushkaryov &amp; Südhof, 1993). mRNA isoform levels dynamically change during neuronal development and in response to external stimuli (Agarwal et al., 2021; Ji et al., 2009; Shepard et al., 2011; J. Wang et al., 2021), and neuronal subtype specification is dependent on the balanced expression of many gene isoforms (Belgard et al., 2011; Gupta et al., 2018; S. He et al., 1998; Kazantseva et al., 2009; Lerch et al., 2012; Lianoglou et al., 2013; Nakahata &amp; Kawamoto, 2005; Reyes &amp; Huber, 2018; Schreiner et al., 2014; Shulman &amp; Elkon, 2019; Stark et al., 2005; Y. Zhang et al., 2014). Over 100 transcriptionally distinct neuronal subtypes have been identified, each expressing shared and unique mRNA isoforms, to achieve the complex neuronal diversity of the human brain (M. B. Johnson et al., 2009; Saunders et al., 2018; Tasic et al., 2016; Zeisel et al., 2018). Thus, it is not surprising that aberrant expression of even a single, critical, gene required for precise control of mRNA splicing fidelity can lead to neurological disorders or neurodegenerative disease (e.g. mutation or deletion of SMN1 in spinal muscular atrophy (S. Lefebvre et al., 1995)).

Selective neuronal vulnerability attempts to describe the differential vulnerability of neurons or specific neuronal subpopulations to disease (Fu, Hardy, &amp; Duff, 2018; Morrison, Hof, &amp; Morrison, 1998; Saxena &amp; Caroni, 2011; Wieloch, 1985). At present, the contributions of gene expression to selective neuronal vulnerability are three-fold: 1) metabolic requirements, 2) activity and communication, and 3) transcriptional processing and protein availability. 1) Neuronal activity is metabolically expensive. The metabolic cost scales linearly with the number of neurons and with body size (Fonseca-Azevedo &amp; Herculano-Houzel, 2012). Many neurons transmit information to and from brain regions or distal organs, and the speed of this transmission is metabolically demanding (Laughlin, de Ruyter van Steveninck, &amp; Anderson, 1998). Furthermore, neurons rely on ion channels to drive electrical activity and maintenance of firing, while ion gradients govern neuronal biophysics (Hasenstaub, Otte, Callaway, &amp; Sejnowski Terrence, 2010). Thus, misprocessing of genes that alter the metabolic load on a neuronal subpopulation likely contributes to loss of that population. 2) Neurons communicate via neurotransmitters. This feature is largely unique to neurons and thus represents an important axis of regulation. Neurotransmitters, such as the excitatory molecule glutamate and the inhibitory molecule γ-aminobutyric acid (GABA), rely on protein transporters and receptors to transmit signals between cells at the synapse. In many cases, transporters and receptors are ligand-specific and loss-of-function due to aberrant co-transcriptional processing can lead to collapse of a signalling pathway (Furlanis et al., 2019; C.-L. G. Lin et al., 1998; Schreiner et al., 2014; Ule et al., 2005). For example, abnormal splicing of glutamate transporter EAAT2 has been identified in ALS samples, and translation products are either rapidly degraded or have a dominant negative effect on the wildtype protein, resulting in loss of protein and activity. This loss of EAAT2 function leads to increased extracellular glutamate and excitotoxic neuronal degeneration (Lin et al 1998). 3) The unique morphological and physiological properties of neurons are achieved and maintained by cell type-specific expression of transcription factors and RBPs. Altered expression of many transcriptional regulators can affect neuronal specification, maturation, and metabolism. To achieve proper splicing of long, neuronal genes, such as genes important for synapse formation, the rate of transcriptional elongation is critical for kinetic coupling with co-transcriptional processes (Maslon et al., 2019). Furthermore, if RBPs required for efficient gene expression are sequestered or unavailable, protein complex stoichiometry can be affected and result in aberrant mRNA processing (Braunschweig et al., 2014; Chou et al., 2018; Jenal et al., 2012; Liu-Yesucevitz et al., 2010). Together, these features of neuronal gene expression emphasize the essential processes that, when disrupted, contribute to selective neuronal vulnerability to disease.

The consequences of altered gene expression in neurons are well-documented. While molecular mechanisms have been dissected for several diseases (e.g. TDP-43-associated ALS, PCH1, and PCH10), many of the molecular mechanisms that underlie disease pathology remain unclear. The contributions of multiple regulatory layers (i.e. gene expression, splicing, and 3’ end processing) are increasingly important for defining, not only disease mechanisms, but also proper neuronal development and maintenance of neuronal plasticity (Ha et al., 2021). Therefore, understanding neuronal gene regulatory networks and how balance of gene isoforms is maintained in health and altered in disease will be invaluable for expanding our understanding of the human nervous system.

Acknowledgments

The authors would like to thank the members of the Schaffer and Philippidou laboratories for thoughtful discussion during manuscript preparation, as well as departmental support from Case Western Reserve University Department of Genetics and Genome Sciences and Neurosciences.

Funding Information

This work was supported by the US National Institute of Health (R01NS5123524 to Ashleigh E. Schaffer; R01NS114510 to Polyxeni Philippidou). Additional support was provided to Geneva R. LaForce by the US National Institute of Health, Ruth L. Kirschstein NRSA F31-Diversity fellowship (F31NS122207).

Figure 1. Neuronal development and the formation of neuronal circuits

(A) Schematic of cortical neuron development. Neuronal progenitors in the ventricular and subventricular zones (VZ and SVZ, respectively), undergo a multi-polar to bi-polar transition, then migrate outward through the intermediate zone (IZ) along radial glia to form the layers of the cerebral cortex.

(B) Schematic of a synapse. Vesicles containing neurotransmitters are released from the pre-synaptic neuron into the synaptic cleft, where ligand-gated ion channel receptors on the post-synaptic neuron receive and transmit electrical signals.

(C) Synaptic connections are established via homophilic interactions of adhesion molecules expressed on the cell surface (left; blue/purple/pink, cell adhesion molecules), secretion of chemoattractants or chemorepellents to guide localized synapse formation (middle), and via neuronal activity stimulated via neurotransmitter release into the chemical microenvironment (right).

Figure 2. Alternative mRNA processing generates isoform diversity.

Each row represents a type of alternative transcript processing. Splice junctions demonstrate inclusion or exclusion of transcript exons/regions (red/purple, alternative inclusion/extension) compared to constitutive exons/regions (black).

Figure 3. Alternative mRNA processing in neurons alters several transcript features.

mRNA processing in neurons is highly regulated and controls several transcript features, including subcellular localization, stability/decay, miRNA-mediated regulation, local translation, protein function, and RNA binding protein (RBP) recruitment.

Table 1. Alternative mRNA processing and human neurological disease

Disease	Processing Type	Effector (if known)	References	
Amyotrophic Lateral Sclerosis	AS, APA, RBPs, RBP sequestration, mislocalization	e.g. TDP-43, FUS, C9ORF72, TIA1, hnRNPA2/B1, hnRNPA1, ATAXN2, SETX, TAF15, MATR3	(Barker, Niblock, Lee, Shaw, &amp; Gallo, 2017; Chou et al., 2018; Klim et al., 2019; Liu-Yesucevitz et al., 2010; Melamed et al., 2019; Neumann et al., 2006; Polymenidou et al., 2011; Tollervey, Curk, et al., 2011; Zhao, Kim, van Bruggen, &amp; Park, 2018)	
Alzheimer’s Disease	AS, APA, RBPs	e.g. PSEN1/2, MAPT, APP, APOE	(Adusumalli et al., 2019; Barbash et al., 2017; Biamonti et al., 2021; De Jonghe et al., 1999; Goedert et al., 1989; Han et al., 2019; Sato et al., 1999; Tollervey, Wang, et al., 2011; Twine, Janitz, Wilkins, &amp; Janitz, 2011)	
Parkinson’s Disease	AS, APA, RBPs	e.g. SCNA, LRRK2, VPS35, PARK2	(Blažeković et al., 2021; Cherian &amp; Divya, 2020; Gaweda-Walerych et al., 2016; Humbert et al., 2007; LaForce et al., 2022; Martin, 2016; Rhinn et al., 2012; Schulze et al., 2018; Simon et al., 2020; Tan et al., 2005)	
Huntington Disease	RBP sequestration, AS, APA	HTT	(DiFiglia et al., 1997; Lunkes et al., 2002; Mykowska et al., 2011; Schilling et al., 2019)	
Pontocerebellar Hypoplasia Type 1 (subtypes B, C, D, F)	Dysregulation of RNA metabolism	EXOSC1, 3, 8, 9	(Morton et al., 2018; Müller et al., 2020)	
Pontocerebellar Hypoplasia Type 10	APA, 3’ UTR lengthening, long gene overexpression	CLP1	(LaForce et al., 2022; Monaghan et al., 2021)	
Rett Syndrome	AS, APA, long gene overexpression	MECP2	(Gabel et al., 2015; Osenberg et al., 2018; Pacheco et al., 2017; K. Sugino et al., 2014; Young et al., 2005)	
Spinal Muscular Atrophy	AS, RBPs	SMN1/2	(Cartegni, Hastings, Calarco, de Stanchina, &amp; Krainer, 2006; Kashima &amp; Manley, 2003)	
Myotonic Dystrophy	RBP sequestration, AS, APA	DMPK, ZFN9	(Jiang, Mankodi, Swanson, Moxley, &amp; Thornton, 2004; Kanadia Rahul et al., 2006; Kanadia et al., 2003; LaForce et al., 2022; Lukáš et al., 2012; Sellier et al., 2018)	
Fragile X Syndrome	RBP sequestration, AS, APA	FMR1	(Ashley et al., 1993; Iwahashi et al., 2006; Tassone et al., 2011; Tassone, Iwahashi, &amp; Hagerman, 2004)	
Paraneoplastic opsoclonus-myoclonus ataxia (POMA)	AS, RBP	NOVA1/2	(Ronald J. Buckanovich et al., 1993; R. J. Buckanovich et al., 1996; Y. Y. L. Yang et al., 1998)	
Autism Spectrum Disorder &amp; Intellectual Disability	AS, APA, RBP misregulation	e.g. RBFOX1, NOVA2, SCAF4, PQBP1, hnRNPH1, CPSF3, NUDT21, CSTF2, NRXN1/2/3, SRRM4, MECP2, FMR1, CPEB4, A2BP1,	(Akawi et al., 2016; Arnadottir et al., 2022; T. Chen et al., 2019; Fliedner et al., 2020; Gennarino et al., 2015; Grozdanov et al., 2020; Hamada et al., 2016; M. Irimia et al., 2014; Y. Lee et al., 2020; L. S. Nguyen et al., 2012; Poirier et al., 2017; Reichert et al., 2020; Tromp, Mowry, &amp; Giacomotto, 2021; Urreizti et al., 2020; Q. Wang et al., 2013)	
Cancer (e.g. Glioblastoma, Neuroblastoma)	AS, APA	e.g. PTBP1, CFIm25, PCF11	(Ferrarese et al., 2014; Masamha et al., 2014; Ogorodnikov et al., 2018)	
Abbreviations: AS, alternative splicing; APA, alternative polyadenylation; RBP, RNA binding protein; UTR, untranslated region

Note: In diseases with multiple genetic causes, an effector gene is listed if it meets the following criteria: 1) mutation of the gene causes the disease and 2) the gene mutation is associated with disease-related changes in mRNA processing.

Conflict of Interest

The authors declare no conflicts of interest for this article.


References

Abrahams BS , &amp; Geschwind DH (2008). Advances in autism genetics: on the threshold of a new neurobiology. Nature Reviews Genetics, 9 (5 ), 341–355. doi:10.1038/nrg2346
Adusumalli S , Ngian Z-K , Lin W-Q , Benoukraf T , &amp; Ong C-T (2019). Increased intron retention is a post-transcriptional signature associated with progressive aging and Alzheimer’s disease. Aging Cell, 18 (3 ), e12928. doi:10.1111/acel.12928 30868713
Agarwal V , Lopez-Darwin S , Kelley DR , &amp; Shendure J (2021). The landscape of alternative polyadenylation in single cells of the developing mouse embryo. Nature Communications, 12 (1 ), 5101. doi:10.1038/s41467-021-25388-8
Akamatsu W , Okano Hirotaka J , Osumi N , Inoue T , Nakamura S , Sakakibara S-I , . . . Okano H . (1999). Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems. Proceedings of the National Academy of Sciences, 96 (17 ), 9885–9890. doi:10.1073/pnas.96.17.9885
Akawi NA , Ben-Salem S , Hertecant J , John A , Pramathan T , Kizhakkedath P , . . . Al-Gazali L . (2016). A homozygous splicing mutation in ELAC2 suggests phenotypic variability including intellectual disability with minimal cardiac involvement. Orphanet Journal of Rare Diseases, 11 (1 ), 139. doi:10.1186/s13023-016-0526-8 27769300
Albert MS , DeKosky ST , Dickson D , Dubois B , Feldman HH , Fox NC , . . . Phelps CH . (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s &amp; Dementia, 7 (3 ), 270–279. doi:10.1016/j.jalz.2011.03.008
Amir RE , Van den Veyver IB , Wan M , Tran CQ , Francke U , &amp; Zoghbi HY (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics, 23 (2 ), 185–188. doi:10.1038/13810 10508514
An JJ , Gharami K , Liao G-Y , Woo NH , Lau AG , Vanevski F , . . . Xu B . (2008). Distinct Role of Long 3′ UTR BDNF mRNA in Spine Morphology and Synaptic Plasticity in Hippocampal Neurons. Cell, 134 (1 ), 175–187. doi:10.1016/j.cell.2008.05.045 18614020
Andrew SE , Paul Goldberg Y , Kremer B , Telenius H , Theilmann J , Adam S , . . . Hayden MR . (1993). The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington’s disease. Nature Genetics, 4 (4 ), 398–403. doi:10.1038/ng0893-398 8401589
Arnadottir GA , Oddsson A , Jensson BO , Gisladottir S , Simon MT , Arnthorsson AO , . . . Stefansson K . (2022). Population-level deficit of homozygosity unveils CPSF3 as an intellectual disability syndrome gene. Nature Communications, 13 (1 ), 705. doi:10.1038/s41467-022-28330-8
Aronin N , K C , Young C , Sapp E , Schwarz C , Matta N , . . . DiFiglia M . (1995). CAG expansion affects the expression of mutant Huntingtin in the Huntington’s disease brain. Neuron, 15 (5 ), 1193–1201.7576661
Ascoli GA , Alonso-Nanclares L , Anderson SA , Barrionuevo G , Benavides-Piccione R , Burkhalter A , . . . The Petilla Interneuron Nomenclature, G. (2008). Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nature Reviews Neuroscience, 9 (7 ), 557–568. doi:10.1038/nrn2402 18568015
Ashiya M , &amp; Grabowski PJ (1997). A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart. RNA, 3 (9 ), 996–1015. Retrieved from http://rnajournal.cshlp.org/content/3/9/996.abstract 9292499
Ashley CT , Sutcliffe JS , Kunst CB , Leiner HA , Eichler EE , Nelson DL , &amp; Warren ST (1993). Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG–repeat. Nature Genetics, 4 (3 ), 244–251. doi:10.1038/ng0793-244 8358432
Barash Y , Calarco JA , Gao W , Pan Q , Wang X , Shai O , . . . Frey BJ . (2010). Deciphering the splicing code. Nature, 465 (7294 ), 53–59. doi:10.1038/nature09000 20445623
Barbash S , Garfinkel BP , Maoz R , Simchovitz A , Nadorp B , Guffanti A , . . . Soreq H . (2017). Alzheimer’s brains show inter-related changes in RNA and lipid metabolism. Neurobiology of Disease, 106 , 1–13. doi:10.1016/j.nbd.2017.06.008 28630030
Bark C , Bellinger FP , Kaushal A , Mathews JR , Partridge LD , &amp; Wilson MC (2004). Developmentally Regulated Switch in Alternatively Spliced SNAP-25 Isoforms Alters Facilitation of Synaptic Transmission. The Journal of Neuroscience, 24 (40 ), 8796. doi:10.1523/JNEUROSCI.1940-04.2004 15470145
Barker HV , Niblock M , Lee Y-B , Shaw CE , &amp; Gallo J-M (2017). RNA Misprocessing in C9orf72-Linked Neurodegeneration. Frontiers in Cellular Neuroscience, 11 . doi:10.3389/fncel.2017.00195
Beaulieu CL , Huang L , Innes AM , Akimenko M-A , Puffenberger EG , Schwartz C , . . . Consortium, F. C. (2013). Intellectual disability associated with a homozygous missense mutation in THOC6. Orphanet Journal of Rare Diseases, 8 (1 ), 62. doi:10.1186/1750-1172-8-62 23621916
Becanovic K , Pouladi MA , Lim RS , Kuhn A , Pavlidis P , Luthi-Carter R , . . . Leavitt BR . (2010). Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis. Human Molecular Genetics, 19 (8 ), 1438–1452. doi:10.1093/hmg/ddq018 20089533
Beites CL , Kawauchi S , &amp; Calof AL (2009). Olfactory Neuron Patterning and Specification. In Squire LR (Ed.), Encyclopedia of Neuroscience (pp. 145–156). Oxford: Academic Press.
Belgard TG , Marques Ana C. , Oliver Peter L. , Abaan HO , Sirey Tamara M. , Hoerder-Suabedissen A , . . . Ponting Chris P . (2011). A Transcriptomic Atlas of Mouse Neocortical Layers. Neuron, 71 (4 ), 605–616. doi:10.1016/j.neuron.2011.06.039 21867878
Berchtold NC , Cribbs DH , Coleman PD , Rogers J , Head E , Kim R , . . . Cotman CW . (2008). Gene expression changes in the course of normal brain aging are sexually dimorphic. Proceedings of the National Academy of Sciences, 105 (40 ), 15605–15610. doi:10.1073/pnas.0806883105
Berg Michael G. , Singh Larry N. , Younis I , Liu Q , Pinto Anna M. , Kaida D , . . . Dreyfuss G (2012). U1 snRNP Determines mRNA Length and Regulates Isoform Expression. Cell, 150 (1 ), 53–64. doi:10.1016/j.cell.2012.05.029 22770214
Berkovits BD , &amp; Mayr C (2015). Alternative 3′ UTRs act as scaffolds to regulate membrane protein localization. Nature, 522 (7556 ), 363–367. doi:10.1038/nature14321 25896326
Berto S , Usui N , Konopka G , &amp; Fogel BL (2016). ELAVL2-regulated transcriptional and splicing networks in human neurons link neurodevelopment and autism. Human Molecular Genetics, 25 (12 ), 2451–2464. doi:10.1093/hmg/ddw110 27260404
Biamonti G , Amato A , Belloni E , Di Matteo A , Infantino L , Pradella D , &amp; Ghigna C (2021). Alternative splicing in Alzheimer’s disease. Aging Clinical and Experimental Research, 33 (4 ), 747–758. doi:10.1007/s40520-019-01360-x 31583531
Bielli P , Pagliarini V , Pieraccioli M , Caggiano C , &amp; Sette C (2020). Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors. Cells, 9 (1 ). doi:10.3390/cells9010010
Birsa N , Bentham MP , &amp; Fratta P (2020). Cytoplasmic functions of TDP-43 and FUS and their role in ALS. Seminars in Cell &amp; Developmental Biology, 99 , 193–201. doi:10.1016/j.semcdb.2019.05.023 31132467
Bishop S , Gahagan S , &amp; Lord C (2007). Re-examining the core features of autism: a comparison of autism spectrum disorder and fetal alcohol spectrum disorder. Journal of Child Psychology and Psychiatry, 48 (11 ), 1111–1121. doi:10.1111/j.1469-7610.2007.01782.x 17995487
Blair JD , Hockemeyer D , Doudna JA , Bateup HS , &amp; Floor SN (2017). Widespread Translational Remodeling during Human Neuronal Differentiation. Cell Reports, 21 (7 ), 2005–2016. doi:10.1016/j.celrep.2017.10.095 29141229
Blažeković A , Jerčić KG , &amp; Borovečki F (2021). SNCA 3’ UTR Genetic Variants in Patients with Parkinson’s Disease. Biomolecules, 11 (12 ). doi:10.3390/biom11121799
Boczonadi V , Müller JS , Pyle A , Munkley J , Dor T , Quartararo J , . . . Horvath R . (2014). EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia. Nature Communications, 5 (1 ), 4287. doi:10.1038/ncomms5287
Boutz PL , Stoilov P , Li Q , Lin C-H , Chawla G , Ostrow K , . . . Black DL . (2007). A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes &amp; Development, 21 (13 ), 1636–1652. doi:10.1101/gad.1558107 17606642
Braunschweig U , Barbosa-Morais NL , Pan Q , Nachman EN , Alipanahi B , Gonatopoulos-Pournatzis T , . . . Blencowe BJ . (2014). Widespread intron retention in mammals functionally tunes transcriptomes. Genome Research, 24 (11 ), 1774–1786. doi:10.1101/gr.177790.114 25258385
Brinkman RR , Mezei MM , Theilmann J , Almqvist E , &amp; Hayden MR (1997). The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. The American Journal of Human Genetics, 60 (5 ), 1202–1210.9150168
Buckanovich RJ , Posner JB , &amp; Darnell RB (1993). Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron, 11 (4 ), 657–672. doi:10.1016/0896-6273(93)90077-5 8398153
Buckanovich RJ , Yang YY , &amp; Darnell RB (1996). The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. The Journal of Neuroscience, 16 (3 ), 1114. doi:10.1523/JNEUROSCI.16-03-01114.1996 8558240
Buljan M , Chalancon G , Eustermann S , Wagner Gunter P. , Fuxreiter M , Bateman A , &amp; Babu MM . (2012). Tissue-Specific Splicing of Disordered Segments that Embed Binding Motifs Rewires Protein Interaction Networks. Molecular Cell, 46 (6 ), 871–883. doi:10.1016/j.molcel.2012.05.039 22749400
Burns DT , Donkervoort S , Müller JS , Knierim E , Bharucha-Goebel D , Faqeih EA , . . . Bönnemann CG . (2018). Variants in EXOSC9 Disrupt the RNA Exosome and Result in Cerebellar Atrophy with Spinal Motor Neuronopathy. The American Journal of Human Genetics, 102 (5 ), 858–873. doi:10.1016/j.ajhg.2018.03.011 29727687
Butti Z , &amp; Patten SA (2019). RNA Dysregulation in Amyotrophic Lateral Sclerosis. Frontiers in Genetics, 9 . doi:10.3389/fgene.2018.00712
Cajigas Iván J. , Tushev G , Will Tristan J. , tom Dieck S , Fuerst N , &amp; Schuman Erin M . (2012). The Local Transcriptome in the Synaptic Neuropil Revealed by Deep Sequencing and High-Resolution Imaging. Neuron, 74 (3 ), 453–466. doi:10.1016/j.neuron.2012.02.036 22578497
Cartegni L , Hastings ML , Calarco JA , de Stanchina E , &amp; Krainer AR (2006). Determinants of Exon 7 Splicing in the Spinal Muscular Atrophy Genes, SMN1 and SMN2. The American Journal of Human Genetics, 78 (1 ), 63–77. doi:10.1086/498853 16385450
Chahrour M , Jung Sung Y , Shaw C , Zhou X , Wong Stephen TC , Qin J , &amp; Zoghbi Huda Y (2008). MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription. Science, 320 (5880 ), 1224–1229. doi:10.1126/science.1153252 18511691
Chau KK , Zhang P , Urresti J , Amar M , Pramod AB , Chen J , . . . Iakoucheva LM . (2021). Full-length isoform transcriptome of the developing human brain provides further insights into autism. Cell Reports, 36 (9 ). doi:10.1016/j.celrep.2021.109631
Chen C , Wirth A , &amp; Ponimaskin E (2012). Cdc42: An important regulator of neuronal morphology. The International Journal of Biochemistry &amp; Cell Biology, 44 (3 ), 447–451. doi:10.1016/j.biocel.2011.11.022 22172377
Chen C-Y , Gherzi R , Ong S-E , Chan EL , Raijmakers R , Pruijn GJM , . . . Karin M . (2001). AU Binding Proteins Recruit the Exosome to Degrade ARE-Containing mRNAs. Cell, 107 (4 ), 451–464. doi:10.1016/S0092-8674(01)00578-5 11719186
Chen T , Zhang B , Ziegenhals T , Prusty AB , Fröhler S , Grimm C , . . . Chen W . (2019). A missense mutation in SNRPE linked to non-syndromal microcephaly interferes with U snRNP assembly and pre-mRNA splicing. PLOS Genetics, 15 (10 ), e1008460. doi:10.1371/journal.pgen.1008460 31671093
Chen WV , Nwakeze CL , Denny CA , O’Keeffe S , Rieger MA , Mountoufaris G , . . . Maniatis T (2017). Pcdhαc2 is required for axonal tiling and assembly of serotonergic circuitries in mice. Science, 356 (6336 ), 406–411. doi:10.1126/science.aal3231 28450636
Chen X , Zhao C , Guo B , Zhao Z , Wang H , &amp; Fang Z (2019). Systematic Profiling of Alternative mRNA Splicing Signature for Predicting Glioblastoma Prognosis. Frontiers in Oncology, 9 . doi:10.3389/fonc.2019.00928
Cherian A , &amp; Divya KP (2020). Genetics of Parkinson’s disease. Acta Neurologica Belgica, 120 (6 ), 1297–1305. doi:10.1007/s13760-020-01473-5 32813147
Chou C-C , Zhang Y , Umoh ME , Vaughan SW , Lorenzini I , Liu F , . . . Rossoll W . (2018). TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nature Neuroscience, 21 (2 ), 228–239. doi:10.1038/s41593-017-0047-3 29311743
Citri A , &amp; Malenka RC (2008). Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms. Neuropsychopharmacology, 33 (1 ), 18–41. doi:10.1038/sj.npp.1301559 17728696
Closser M , Guo Y , Wang P , Patel T , Jang S , Hammelman J , . . . Wichterle H . (2022). An expansion of the non-coding genome and its regulatory potential underlies vertebrate neuronal diversity. Neuron, 110 (1 ), 70–85.e76. doi:10.1016/j.neuron.2021.10.014 34727520
Colantuoni C , Lipska BK , Ye T , Hyde TM , Tao R , Leek JT , . . . Kleinman JE . (2011). Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature, 478 (7370 ), 519–523. doi:10.1038/nature10524 22031444
Conboy J (2016). Developmental regulation of RNA processing by Rbfox proteins. WIREs RNA, 8 (2 ), e1398. doi: 10.1002/1398
D’Arcangelo G , Miao G , G. , Chen S-C , Scares HD , Morgan JI , &amp; Curran T (1995). A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature, 374 (6524 ), 719–723. doi:10.1038/374719a0 7715726
Damianov A , &amp; Black DL (2010). Autoregulation of Fox protein expression to produce dominant negative splicing factors. RNA, 16 (2 ), 405–416. doi:10.1261/rna.1838210 20042473
de Graaf-Peters VB , &amp; Hadders-Algra M (2006). Ontogeny of the human central nervous system: What is happening when? Early Human Development, 82 (4 ), 257–266. doi:10.1016/j.earlhumdev.2005.10.013 16360292
De Jonghe C , MarcCruts Rogaeva, E. A. , Tysoe C , Singleton A , Vanderstichele H , . . . Van Broeckhoven C . (1999). Aberrant Splicing in the Presenilin-1 Intron 4 Mutation Causes Presenile Alzheimer’s Disease by Increased Aβ42 Secretion. Human Molecular Genetics, 8 (8 ), 1529–1540. doi:10.1093/hmg/8.8.1529 10401002
de Vries H , Rüegsegger U , Hübner W , Friedlein A , Langen H , &amp; Keller W (2000). Human pre-mRNA cleavage factor IIm contains homologs of yeast proteins and bridges two other cleavage factors. The EMBO Journal, 19 (21 ), 5895–5904. doi:10.1093/emboj/19.21.5895 11060040
DeFelipe J , Alonso-Nanclares L , &amp; Arellano JI (2002). Microstructure of the neocortex: Comparative aspects. Journal of Neurocytology, 31 (3 ), 299–316. doi:10.1023/A:1024130211265 12815249
Derti A , Garrett-Engele P , MacIsaac KD , Stevens RC , Sriram S , Chen R , . . . Babak T . (2012). A quantitative atlas of polyadenylation in five mammals. Genome Research, 22 (6 ), 1173–1183. doi:10.1101/gr.132563.111 22454233
Desai J , Velo MPR , Yamada K , Overman LM , &amp; Engle EC (2012). Spatiotemporal expression pattern of KIF21A during normal embryonic development and in congenital fibrosis of the extraocular muscles type 1 (CFEOM1). Gene Expression Patterns, 12 (5 ), 180–188. doi:10.1016/j.gep.2012.03.003 22465342
DiFiglia M , Sapp E , Chase Kathryn O , Davies Stephen W , Bates Gillian P , Vonsattel JP , &amp; Aronin N (1997). Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain. Science, 277 (5334 ), 1990–1993. doi:10.1126/science.277.5334.1990 9302293
Ding Q , Dimayuga E , Markesbery WR , &amp; Keller JN (2004). Proteasome inhibition increases DNA and RNA oxidation in astrocyte and neuron cultures. Journal of Neurochemistry, 91 (5 ), 1211–1218. doi:10.1111/j.1471-4159.2004.02802.x 15569264
Dobrott CI , Sathyamurthy A , &amp; Levine AJ (2019). Decoding cell type diversity within the spinal cord. Current Opinion in Physiology, 8 , 1–6. doi:10.1016/j.cophys.2018.11.006 31572830
Donkervoort S , Müller J , Knierim E , Bharucha-Goebel D , Dyack S , Burns D , . . . Bönnemann C . (2017). Recessive mutation in EXOSC9 disrupts the exosome complex resulting in a novel form of cerebellar hypoplasia/atrophy with early motor neuronopathy. Neuromuscular Disorders, 27 , S176–S177. doi:10.1016/j.nmd.2017.06.303
Donlin-Asp PG , Polisseni C , Klimek R , Heckel A , &amp; Schuman EM (2021). Differential regulation of local mRNA dynamics and translation following long-term potentiation and depression. Proceedings of the National Academy of Sciences, 118 (13 ), e2017578118. doi:10.1073/pnas.2017578118
Dredge BK , Stefani G , Engelhard CC , &amp; Darnell RB (2005). Nova autoregulation reveals dual functions in neuronal splicing. The EMBO Journal, 24 (8 ), 1608–1620. doi:10.1038/sj.emboj.7600630 15933722
Duda J , Pötschke C , &amp; Liss B (2016). Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson’s disease. Journal of Neurochemistry, 139 (S1 ), 156–178. doi:10.1111/jnc.13572 26865375
Duyao M , Ambrose C , Myers R , Novelletto A , Persichetti F , Frontali M , . . . MacDonald M . (1993). Trinucleotide repeat length instability and age of onset in Huntington’s disease. Nature Genetics, 4 (4 ), 387–392. doi:10.1038/ng0893-387 8401587
Ehrmann I , Gazzara MR , Pagliarini V , Dalgliesh C , Kheirollahi-Chadegani M , Xu Y , . . . Elliott DJ . (2016). A SLM2 Feedback Pathway Controls Cortical Network Activity and Mouse Behavior. Cell Reports, 17 (12 ), 3269–3280. doi:10.1016/j.celrep.2016.12.002 28009295
Ellis Jonathan D. , Barrios-Rodiles M , Çolak R , Irimia M , Kim T , Calarco John A. , . . . Blencowe Benjamin J . (2012). Tissue-Specific Alternative Splicing Remodels Protein-Protein Interaction Networks. Molecular Cell, 46 (6 ), 884–892. doi:10.1016/j.molcel.2012.05.037 22749401
Esumi S , Kakazu N , Taguchi Y , Hirayama T , Sasaki A , Hirabayashi T , . . . Yagi T . (2005). Monoallelic yet combinatorial expression of variable exons of the protocadherin-α gene cluster in single neurons. Nature Genetics, 37 (2 ), 171–176. doi:10.1038/ng1500 15640798
Ferrarese R , Harsh GRIV , Yadav AK , Bug E , Maticzka D , Reichardt W , . . . Bredel M . (2014). Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression. The Journal of Clinical Investigation, 124 (7 ), 2861–2876. doi:10.1172/JCI68836 24865424
Filipowicz W , Bhattacharyya SN , &amp; Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics, 9 (2 ), 102–114. doi:10.1038/nrg2290
Fiore R , &amp; Püschel AW (2003). The function of semaphorins during nervous system development. Frontiers in bioscience : a journal and virtual library, 8 , s484–499. doi:10.2741/1080. (Accession No. 12700098) 12700098
Flavell SW , Kim T-K , Gray JM , Harmin DA , Hemberg M , Hong EJ , . . . Greenberg ME . (2008). Genome-Wide Analysis of MEF2 Transcriptional Program Reveals Synaptic Target Genes and Neuronal Activity-Dependent Polyadenylation Site Selection. Neuron, 60 (6 ), 1022–1038. doi:10.1016/j.neuron.2008.11.029 19109909
Fliedner A , Kirchner P , Wiesener A , van de Beek I , Waisfisz Q , van Haelst M , . . . Zweier C . (2020). Variants in SCAF4 Cause a Neurodevelopmental Disorder and Are Associated with Impaired mRNA Processing. The American Journal of Human Genetics, 107 (3 ), 544–554. doi:10.1016/j.ajhg.2020.06.019 32730804
Fonseca-Azevedo K , &amp; Herculano-Houzel S (2012). Metabolic constraint imposes tradeoff between body size and number of brain neurons in human evolution. Proceedings of the National Academy of Sciences, 109 (45 ), 18571–18576. doi:10.1073/pnas.1206390109
Fontes MM , Guvenek A , Kawaguchi R , Zheng D , Huang A , Ho VM , . . . Martin KC . (2017). Activity-Dependent Regulation of Alternative Cleavage and Polyadenylation During Hippocampal Long-Term Potentiation. Scientific Reports, 7 (1 ), 17377. doi:10.1038/s41598-017-17407-w 29234016
Frankiw L , Baltimore D , &amp; Li G (2019). Alternative mRNA splicing in cancer immunotherapy. Nature Reviews Immunology, 19 (11 ), 675–687. doi:10.1038/s41577-019-0195-7
Fu H , Hardy J , &amp; Duff KE (2018). Selective vulnerability in neurodegenerative diseases. Nature Neuroscience, 21 (10 ), 1350–1358. doi:10.1038/s41593-018-0221-2 30250262
Fuccillo Marc V. , Földy C , Gökce Ö , Rothwell Patrick E. , Sun Gordon L. , Malenka Robert C. , &amp; Südhof Thomas C . (2015). Single-Cell mRNA Profiling Reveals Cell-Type-Specific Expression of Neurexin Isoforms. Neuron, 87 (2 ), 326–340. doi:10.1016/j.neuron.2015.06.028 26182417
Furlanis E , Traunmüller L , Fucile G , &amp; Scheiffele P (2019). Landscape of ribosome-engaged transcript isoforms reveals extensive neuronal-cell-class-specific alternative splicing programs. Nature Neuroscience, 22 (10 ), 1709–1717. doi:10.1038/s41593-019-0465-5 31451803
Gabel HW , Kinde B , Stroud H , Gilbert CS , Harmin DA , Kastan NR , . . . Greenberg ME . (2015). Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Nature, 522 (7554 ), 89–93. doi:10.1038/nature14319 25762136
Gatz M , Reynolds CA , Fratiglioni L , Johansson B , Mortimer JA , Berg S , . . . Pedersen NL . (2006). Role of Genes and Environments for Explaining Alzheimer Disease. Archives of General Psychiatry, 63 (2 ), 168–174. doi:10.1001/archpsyc.63.2.168 16461860
Gaweda-Walerych K , Mohagheghi F , Zekanowski C , &amp; Buratti E (2016). Parkinson’s disease–related gene variants influence pre-mRNA splicing processes. Neurobiology of Aging, 47 , 127–138. doi:10.1016/j.neurobiolaging.2016.07.014 27574110
Gehman LT , Stoilov P , Maguire J , Damianov A , Lin C-H , Shiue L , . . . Black DL . (2011). The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain. Nature Genetics, 43 (7 ), 706–711. doi:10.1038/ng.841 21623373
Gennarino VA , Alcott CE , Chen C-A , Chaudhury A , Gillentine MA , Rosenfeld JA , . . . Zoghbi HY . (2015). NUDT21-spanning CNVs lead to neuropsychiatric disease and altered MeCP2 abundance via alternative polyadenylation. eLife, 4 , e10782. doi:10.7554/eLife.10782 26312503
Gitcho MA , Baloh RH , Chakraverty S , Mayo K , Norton JB , Levitch D , . . . Cairns NJ . (2008). TDP-43 A315T mutation in familial motor neuron disease. Annals of Neurology, 63 (4 ), 535–538. doi:10.1002/ana.21344 18288693
Glasser MF , Coalson TS , Robinson EC , Hacker CD , Harwell J , Yacoub E , . . . Van Essen DC . (2016). A multi-modal parcellation of human cerebral cortex. Nature, 536 (7615 ), 171–178. doi:10.1038/nature18933 27437579
Goedert M , Spillantini MG , Jakes R , Rutherford D , &amp; Crowther RA (1989). Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron, 3 (4 ), 519–526. doi:10.1016/0896-6273(89)90210-9 2484340
Goldman SM , Marek K , Ottman R , Meng C , Comyns K , Chan P , . . . Tanner CM . (2019). Concordance for Parkinson’s disease in twins: A 20-year update. Annals of Neurology, 85 (4 ), 600–605. doi:10.1002/ana.25441 30786044
Grozdanov PN , Masoumzadeh E , Kalscheuer VM , Bienvenu T , Billuart P , Delrue M-A , . . . MacDonald CC . (2020). A missense mutation in the CSTF2 gene that impairs the function of the RNA recognition motif and causes defects in 3′ end processing is associated with intellectual disability in humans. Nucleic Acids Research, 48 (17 ), 9804–9821. doi:10.1093/nar/gkaa689 32816001
Guerra San Juan I , Nash LA , Smith KS , Leyton-Jaimes MF , Qian M , Klim JR , . . . Eggan K . (2022). Loss of mouse Stmn2 function causes motor neuropathy. Neuron. doi:10.1016/j.neuron.2022.02.011
Gumy LF , Yeo GSH , Tung Y-CL , Zivraj KH , Willis D , Coppola G , . . . Fawcett JW . (2011). Transcriptome analysis of embryonic and adult sensory axons reveals changes in mRNA repertoire localization. RNA, 17 (1 ), 85–98. doi:10.1261/rna.2386111 21098654
Gupta I , Collier PG , Haase B , Mahfouz A , Joglekar A , Floyd T , . . . Tilgner HU . (2018). Single-cell isoform RNA sequencing characterizes isoforms in thousands of cerebellar cells. Nature Biotechnology, 36 (12 ), 1197–1202. doi:10.1038/nbt.4259
Guvenek A , &amp; Tian B (2018). Analysis of alternative cleavage and polyadenylation in mature and differentiating neurons using RNA-seq data. Quantitative Biology, 6 (3 ), 253–266. doi:10.1007/s40484-018-0148-3 31380142
Ha KCH , Sterne-Weiler T , Morris Q , Weatheritt RJ , &amp; Blencowe BJ (2021). Differential contribution of transcriptomic regulatory layers in the definition of neuronal identity. Nature Communications, 12 (1 ), 335. doi:10.1038/s41467-020-20483-8
Hagberg B , Aicardi J , Dias K , &amp; Ramos O (1983). A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: Report of 35 cases. Annals of Neurology, 14 (4 ), 471–479. doi:10.1002/ana.410140412 6638958
Hamada N , Ito H , Nishijo T , Iwamoto I , Morishita R , Tabata H , . . . Nagata K-I . (2016). Essential role of the nuclear isoform of RBFOX1, a candidate gene for autism spectrum disorders, in the brain development. Scientific Reports, 6 (1 ), 30805. doi:10.1038/srep30805 27481563
Han S , Miller JE , Byun S , Kim D , Risacher SL , Saykin AJ , . . . for Alzheimer’s Disease Neuroimaging, I. (2019). Identification of exon skipping events associated with Alzheimer’s disease in the human hippocampus. BMC Medical Genomics, 12 (1 ), 13. doi:10.1186/s12920-018-0453-8 30704480
Hasenstaub A , Otte S , Callaway E , &amp; Sejnowski Terrence J (2010). Metabolic cost as a unifying principle governing neuronal biophysics. Proceedings of the National Academy of Sciences, 107 (27 ), 12329–12334. doi:10.1073/pnas.0914886107
He C-W , Liao C-P , &amp; Pan C-L (2018). Wnt signalling in the development of axon, dendrites and synapses. Open Biology, 8 (10 ), 180116. doi:10.1098/rsob.180116 30282660
He S , Ruknudin A , Bambrick LL , Lederer WJ , &amp; Schulze DH (1998). Isoform-Specific Regulation of the Na+/Ca2+ Exchanger in Rat Astrocytes and Neurons by PKA. The Journal of Neuroscience, 18 (13 ), 4833. doi:10.1523/JNEUROSCI.18-13-04833.1998 9634549
Heckman EL , &amp; Doe CQ (2021). Establishment and Maintenance of Neural Circuit Architecture. The Journal of Neuroscience, 41 (6 ), 1119. doi:10.1523/JNEUROSCI.1143-20.2020 33568445
Herculano-Houzel S (2009). The human brain in numbers: a linearly scaled-up primate brain. Frontiers in Human Neuroscience, 3 . doi:10.3389/neuro.09.031.2009
Hilgers V , Perry Michael W , Hendrix D , Stark A , Levine M , &amp; Haley B (2011). Neural-specific elongation of 3′ UTRs during Drosophila development. Proceedings of the National Academy of Sciences, 108 (38 ), 15864–15869. doi:10.1073/pnas.1112672108
Hirano K , Kaneko R , Izawa T , Kawaguchi M , Kitsukawa T , &amp; Yagi T (2012). Single-neuron diversity generated by Protocadherin-β cluster in mouse central and peripheral nervous systems. Frontiers in Molecular Neuroscience, 5 . doi:10.3389/fnmol.2012.00090
Ho VM , Lee J-A , &amp; Martin KC (2011). The Cell Biology of Synaptic Plasticity. Science, 334 (6056 ), 623–628. doi:10.1126/science.1209236 22053042
Hoffman Y , Bublik DR , Ugalde P , A. , Elkon R , Biniashvili T , Agami R , . . . Pilpel Y . (2016). 3’UTR Shortening Potentiates MicroRNA-Based Repression of Pro-differentiation Genes in Proliferating Human Cells. PLOS Genetics, 12 (2 ), e1005879. doi:10.1371/journal.pgen.1005879 26908102
Hoque M , Ji Z , Zheng D , Luo W , Li W , You B , . . . Tian B . (2013). Analysis of alternative cleavage and polyadenylation by 3′ region extraction and deep sequencing. Nature Methods, 10 (2 ), 133–139. doi:10.1038/nmeth.2288 23241633
Hua JY , &amp; Smith SJ (2004). Neural activity and the dynamics of central nervous system development. Nature Neuroscience, 7 (4 ), 327–332. doi:10.1038/nn1218 15048120
Hughes AC , Mort M , Elliston L , Thomas RM , Brooks SP , Dunnett SB , &amp; Jones L (2014). Identification of Novel Alternative Splicing Events in the Huntingtin Gene and Assessment of the Functional Consequences Using Structural Protein Homology Modelling. Journal of Molecular Biology, 426 (7 ), 1428–1438. doi:10.1016/j.jmb.2013.12.028 24389360
Humbert J , Beyer K , Carrato C , Mate JL , Ferrer I , &amp; Ariza A (2007). Parkin and synphilin-1 isoform expression changes in Lewy body diseases. Neurobiology of Disease, 26 (3 ), 681–687. doi:10.1016/j.nbd.2007.03.007 17467279
Huttenlocher PR (1979). Synaptic density in human frontal cortex — Developmental changes and effects of aging. Brain Research, 163 (2 ), 195–205. doi:10.1016/0006-8993(79)90349-4 427544
Hwang H-W , Saito Y , Park CY , Blachère NE , Tajima Y , Fak JJ , . . . Darnell RB . (2017). cTag-PAPERCLIP Reveals Alternative Polyadenylation Promotes Cell-Type Specific Protein Diversity and Shifts Araf Isoforms with Microglia Activation. Neuron, 95 (6 ), 1334–1349.e1335. doi:10.1016/j.neuron.2017.08.024 28910620
Iijima T , Iijima Y , Witte H , &amp; Scheiffele P (2014). Neuronal cell type–specific alternative splicing is regulated by the KH domain protein SLM1. Journal of Cell Biology, 204 (3 ), 331–342. doi:10.1083/jcb.201310136 24469635
Iijima T , Wu K , Witte H , Hanno-Iijima Y , Glatter T , Richard S , &amp; Scheiffele P (2011). SAM68 Regulates Neuronal Activity-Dependent Alternative Splicing of Neurexin-1. Cell, 147 (7 ), 1601–1614. doi:10.1016/j.cell.2011.11.028 22196734
Ince-Dunn G , Okano Hirotaka J. , Jensen KB , Park W-Y , Zhong R , Ule J , . . . Darnell Robert B . (2012). Neuronal Elav-like (Hu) Proteins Regulate RNA Splicing and Abundance to Control Glutamate Levels and Neuronal Excitability. Neuron, 75 (6 ), 1067–1080. doi:10.1016/j.neuron.2012.07.009 22998874
Irimia A , Chambers MC , Torgerson CM , &amp; Van Horn JD (2012). Circular representation of human cortical networks for subject and population-level connectomic visualization. NeuroImage, 60 (2 ), 1340–1351. doi:10.1016/j.neuroimage.2012.01.107 22305988
Irimia M , Weatheritt Robert J. , Ellis JD , Parikshak Neelroop N. , Gonatopoulos-Pournatzis T , Babor M , . . . Blencowe Benjamin J . (2014). A Highly Conserved Program of Neuronal Microexons Is Misregulated in Autistic Brains. Cell, 159 (7 ), 1511–1523. doi:10.1016/j.cell.2014.11.035 25525873
Ittner LM , &amp; Götz J (2011). Amyloid-β and tau — a toxic pas de deux in Alzheimer’s disease. Nature Reviews Neuroscience, 12 (2 ), 67–72. doi:10.1038/nrn2967
Iwahashi CK , Yasui DH , An HJ , Greco CM , Tassone F , Nannen K , . . . Hagerman PJ . (2006). Protein composition of the intranuclear inclusions of FXTAS. Brain, 129 (1 ), 256–271. doi:10.1093/brain/awh650 16246864
Jacko M , Weyn-Vanhentenryck SM , Smerdon JW , Yan R , Feng H , Williams DJ , . . . Zhang C . (2018). Rbfox Splicing Factors Promote Neuronal Maturation and Axon Initial Segment Assembly. Neuron, 97 (4 ), 853–868.e856. doi:10.1016/j.neuron.2018.01.020 29398366
Jangi M , Boutz PL , Paul P , &amp; Sharp PA (2014). Rbfox2 controls autoregulation in RNA-binding protein networks. Genes &amp; Development, 28 (6 ), 637–651. doi:10.1101/gad.235770.113 24637117
Jelen N , Ule J , Živin M , &amp; Darnell RB (2007). Evolution of Nova-Dependent Splicing Regulation in the Brain. PLOS Genetics, 3 (10 ), e173. doi:10.1371/journal.pgen.0030173 17937501
Jenal M , Elkon R , Loayza-Puch F , van Haaften G , Kühn U , Menzies Fiona M. , . . . Agami R . (2012). The Poly(A)-Binding Protein Nuclear 1 Suppresses Alternative Cleavage and Polyadenylation Sites. Cell, 149 (3 ), 538–553. doi:10.1016/j.cell.2012.03.022 22502866
Jensen KB , Dredge BK , Stefani G , Zhong R , Buckanovich RJ , Okano HJ , . . . Darnell RB . (2000). Nova-1 Regulates Neuron-Specific Alternative Splicing and Is Essential for Neuronal Viability. Neuron, 25 (2 ), 359–371. doi:10.1016/S0896-6273(00)80900-9 10719891
Ji Z , Lee Ju Y , Pan Z , Jiang B , &amp; Tian B (2009). Progressive lengthening of 3′ untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proceedings of the National Academy of Sciences, 106 (17 ), 7028–7033. doi:10.1073/pnas.0900028106
Ji Z , &amp; Tian B (2009). Reprogramming of 3′ Untranslated Regions of mRNAs by Alternative Polyadenylation in Generation of Pluripotent Stem Cells from Different Cell Types. PLOS ONE, 4 (12 ), e8419. doi:10.1371/journal.pone.0008419 20037631
Jiang Cecilia H , Tsien Joe Z , Schultz Peter G , &amp; Hu Y (2001). The effects of aging on gene expression in the hypothalamus and cortex of mice. Proceedings of the National Academy of Sciences, 98 (4 ), 1930–1934. doi:10.1073/pnas.98.4.1930
Jiang H , Mankodi A , Swanson MS , Moxley RT , &amp; Thornton CA (2004). Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Human Molecular Genetics, 13 (24 ), 3079–3088. doi:10.1093/hmg/ddh327 15496431
Johnson ECB , Dammer EB , Duong DM , Yin L , Thambisetty M , Troncoso JC , . . . Seyfried NT . (2018). Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Molecular Neurodegeneration, 13 (1 ), 52. doi:10.1186/s13024-018-0282-4 30286791
Johnson MB , Kawasawa YI , Mason CE , Krsnik Ž , Coppola G , Bogdanović D , . . . Šestan N . (2009). Functional and Evolutionary Insights into Human Brain Development through Global Transcriptome Analysis. Neuron, 62 (4 ), 494–509. doi:10.1016/j.neuron.2009.03.027 19477152
Joo Y , &amp; Benavides DR (2021). Local Protein Translation and RNA Processing of Synaptic Proteins in Autism Spectrum Disorder. International Journal of Molecular Sciences, 22 (6 ). doi:10.3390/ijms22062811
Junghans D , Heidenreich M , Hack I , Taylor V , Frotscher M , &amp; Kemler R (2008). Postsynaptic and differential localization to neuronal subtypes of protocadherin β16 in the mammalian central nervous system. European Journal of Neuroscience, 27 (3 ), 559–571. doi:10.1111/j.1460-9568.2008.06052.x 18279309
Kabashi E , Valdmanis PN , Dion P , Spiegelman D , McConkey BJ , Velde CV , . . . Rouleau GA . (2008). TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nature Genetics, 40 (5 ), 572–574. doi:10.1038/ng.132 18372902
Kaida D , Berg MG , Younis I , Kasim M , Singh LN , Wan L , &amp; Dreyfuss G (2010). U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature, 468 (7324 ), 664–668. doi:10.1038/nature09479 20881964
Kallenbach S , Khantane S , Carroll P , Gayet O , Alonso S , Henderson CE , &amp; Dudley K (2003). Changes in subcellular distribution of protocadherin gamma proteins accompany maturation of spinal neurons. Journal of Neuroscience Research, 72 (5 ), 549–556. doi:10.1002/jnr.10618 12749019
Kanadia Rahul N , Shin J , Yuan Y , Beattie Stuart G , Wheeler Thurman M , Thornton Charles A , &amp; Swanson Maurice S (2006). Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proceedings of the National Academy of Sciences, 103 (31 ), 11748–11753. doi:10.1073/pnas.0604970103
Kanadia RN , Johnstone KA , Mankodi A , Lungu C , Thornton CA , Esson D , . . . Swanson MS . (2003). A Muscleblind Knockout Model for Myotonic Dystrophy. Science, 302 (5652 ), 1978–1980. doi:10.1126/science.1088583 14671308
Kaneko R , Kato H , Kawamura Y , Esumi S , Hirayama T , Hirabayashi T , &amp; Yagi T (2006). Allelic Gene Regulation of Pcdh-α and Pcdh-γ Clusters Involving Both Monoallelic and Biallelic Expression in Single Purkinje Cells. Journal of Biological Chemistry, 281 (41 ), 30551–30560. doi:10.1074/jbc.M605677200 16893882
Karaca E , Weitzer S , Pehlivan D , Shiraishi H , Gogakos T , Hanada T , . . . Lupski James R . (2014). Human CLP1 Mutations Alter tRNA Biogenesis, Affecting Both Peripheral and Central Nervous System Function. Cell, 157 (3 ), 636–650. doi:10.1016/j.cell.2014.02.058 24766809
Kashima T , &amp; Manley JL (2003). A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nature Genetics, 34 (4 ), 460–463. doi:10.1038/ng1207 12833158
Katori S , Noguchi-Katori Y , Okayama A , Kawamura Y , Luo W , Sakimura K , . . . Yagi T . (2017). Protocadherin-αC2 is required for diffuse projections of serotonergic axons. Scientific Reports, 7 (1 ), 15908. doi:10.1038/s41598-017-16120-y 29162883
Katz LC , &amp; Shatz CJ (1996). Synaptic Activity and the Construction of Cortical Circuits. Science, 274 (5290 ), 1133–1138. doi:10.1126/science.274.5290.1133 8895456
Kazantseva A , Sepp M , Kazantseva J , Sadam H , Pruunsild P , Timmusk T , . . . Palm K . (2009). N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons. Journal of Neurochemistry, 109 (3 ), 807–818. doi:10.1111/j.1471-4159.2009.06005.x 19245665
Kelleher RJ III , Govindarajan A , &amp; Tonegawa S (2004). Translational Regulatory Mechanisms in Persistent Forms of Synaptic Plasticity. Neuron, 44 (1 ), 59–73. doi:10.1016/j.neuron.2004.09.013 15450160
Kilchert C , Wittmann S , &amp; Vasiljeva L (2016). The regulation and functions of the nuclear RNA exosome complex. Nature Reviews Molecular Cell Biology, 17 (4 ), 227–239. doi:10.1038/nrm.2015.15 26726035
King IF , Yandava CN , Mabb AM , Hsiao JS , Huang H-S , Pearson BL , . . . Zylka MJ . (2013). Topoisomerases facilitate transcription of long genes linked to autism. Nature, 501 (7465 ), 58–62. doi:10.1038/nature12504 23995680
Kleiman R , Banker G , &amp; Steward O (1990). Differential subcellular localization of particular mRNAs in hippocampal neurons in culture. Neuron, 5 (6 ), 821–830. doi:10.1016/0896-6273(90)90341-C 2148488
Klim JR , Williams LA , Limone F , Guerra San Juan I , Davis-Dusenbery BN , Mordes DA , . . . Eggan K . (2019). ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nature Neuroscience, 22 (2 ), 167–179. doi:10.1038/s41593-018-0300-4 30643292
Kohmura N , Senzaki K , Hamada S , Kai N , Yasuda R , Watanabe M , . . . Yagi T . (1998). Diversity Revealed by a Novel Family of Cadherins Expressed in Neurons at a Synaptic Complex. Neuron, 20 (6 ), 1137–1151. doi:10.1016/S0896-6273(00)80495-X 9655502
Kriaucionis S , &amp; Bird A (2004). The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Research, 32 (5 ), 1818–1823. doi:10.1093/nar/gkh349 15034150
Kumar R , Corbett Mark A. , van Bon, Bregje WM , Woenig Joshua A. , Weir L , Douglas E , . . . Gecz J (2015). THOC2 Mutations Implicate mRNA-Export Pathway in X-Linked Intellectual Disability. The American Journal of Human Genetics, 97 (2 ), 302–310. doi:10.1016/j.ajhg.2015.05.021 26166480
LaForce GR , Farr JS , Liu J , Akesson C , Gumus E , Pinkard O , . . . Schaffer AE . (2022). Suppression of premature transcription termination leads to reduced mRNA isoform diversity and neurodegeneration. Neuron. doi:10.1016/j.neuron.2022.01.018
Lagier-Tourenne C , Polymenidou M , &amp; Cleveland DW (2010). TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Human Molecular Genetics, 19 (R1 ), R46–R64. doi:10.1093/hmg/ddq137 20400460
Lambolez B , Ropert N , Perrais D , Rossier J , &amp; Hestrin S (1996). Correlation between kinetics and RNA splicing of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in neocortical neurons. Proceedings of the National Academy of Sciences, 93 (5 ), 1797–1802. doi:10.1073/pnas.93.5.1797
Lau AG , Irier HA , Gu J , Tian D , Ku L , Liu G , . . . Feng Y . (2010). Distinct 3′UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF). Proceedings of the National Academy of Sciences, 107 (36 ), 15945–15950. doi:10.1073/pnas.1002929107
Laughlin SB , de Ruyter van Steveninck RR , &amp; Anderson JC . (1998). The metabolic cost of neural information. Nature Neuroscience, 1 (1 ), 36–41. doi:10.1038/236 10195106
Lee H , Engel U , Rusch J , Scherrer S , Sheard K , &amp; Van Vactor D (2004). The Microtubule Plus End Tracking Protein Orbit/MAST/CLASP Acts Downstream of the Tyrosine Kinase Abl in Mediating Axon Guidance. Neuron, 42 (6 ), 913–926. doi:10.1016/j.neuron.2004.05.020 15207236
Lee PR , &amp; Fields RD (2020). Activity-Dependent Gene Expression in Neurons. The Neuroscientist, 27 (4 ), 355–366. doi:10.1177/1073858420943515 32727285
Lee S , Wei L , Zhang B , Goering R , Majumdar S , Wen J , . . . Lai EC . (2021). ELAV/Hu RNA binding proteins determine multiple programs of neural alternative splicing. PLOS Genetics, 17 (4 ), e1009439. doi:10.1371/journal.pgen.1009439 33826609
Lee Y , Zhang Y , Kang H , Bang G , Kim Y , Kang HR , . . . Han K . (2020). Epilepsy- and intellectual disability-associated CYFIP2 interacts with both actin regulators and RNA-binding proteins in the neonatal mouse forebrain. Biochemical and Biophysical Research Communications, 529 (1 ), 1–6. doi:10.1016/j.bbrc.2020.05.221 32560809
Lefebvre JL , Kostadinov D , Chen WV , Maniatis T , &amp; Sanes JR (2012). Protocadherins mediate dendritic self-avoidance in the mammalian nervous system. Nature, 488 (7412 ), 517–521. doi:10.1038/nature11305 22842903
Lefebvre S , Bürglen L , Reboullet S , Clermont O , Burlet P , Viollet L , . . . Melki J . (1995). Identification and characterization of a spinal muscular atrophy-determining gene. Cell, 80 (1 ), 155–165. doi:10.1016/0092-8674(95)90460-3 7813012
Leggere JC , Saito Y , Darnell RB , Tessier-Lavigne M , Junge HJ , &amp; Chen Z (2016). NOVA regulates Dcc alternative splicing during neuronal migration and axon guidance in the spinal cord. eLife, 5 , e14264. doi:10.7554/eLife.14264 27223328
Lerch JK , Kuo F , Motti D , Morris R , Bixby JL , &amp; Lemmon VP (2012). Isoform Diversity and Regulation in Peripheral and Central Neurons Revealed through RNA-Seq. PLOS ONE, 7 (1 ), e30417. doi:10.1371/journal.pone.0030417 22272348
Lewis BP , Burge CB , &amp; Bartel DP (2005). Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets. Cell, 120 (1 ), 15–20. doi:10.1016/j.cell.2004.12.035 15652477
Lewis BP , Green RE , &amp; Brenner SE (2003). Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proceedings of the National Academy of Sciences, 100 (1 ), 189–192. doi:10.1073/pnas.0136770100
Li Q , Zheng S , Han A , Lin C-H , Stoilov P , Fu X-D , &amp; Black DL (2014). The splicing regulator PTBP2 controls a program of embryonic splicing required for neuronal maturation. eLife, 3 , e01201. doi:10.7554/eLife.01201 24448406
Li R , Dong Q , Yuan X , Zeng X , Gao Y , Chiao C , . . . Chang Q . (2016). Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome. PLOS Genetics, 12 (6 ), e1006129. doi:10.1371/journal.pgen.1006129 27352031
Li W , Park JY , Zheng D , Hoque M , Yehia G , &amp; Tian B (2016). Alternative cleavage and polyadenylation in spermatogenesis connects chromatin regulation with post-transcriptional control. BMC Biology, 14 (1 ), 6. doi:10.1186/s12915-016-0229-6 26801249
Li W , You B , Hoque M , Zheng D , Luo W , Ji Z , . . . Tian B . (2015). Systematic Profiling of Poly(A)+ Transcripts Modulated by Core 3’ End Processing and Splicing Factors Reveals Regulatory Rules of Alternative Cleavage and Polyadenylation. PLOS Genetics, 11 (4 ), e1005166. doi:10.1371/journal.pgen.1005166 25906188
Lianoglou S , Garg V , Yang JL , Leslie CS , &amp; Mayr C (2013). Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression. Genes &amp; Development, 27 (21 ), 2380–2396. doi:10.1101/gad.229328.113 24145798
Licatalosi DD , Mele A , Fak JJ , Ule J , Kayikci M , Chi SW , . . . Darnell RB . (2008). HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature, 456 (7221 ), 464–469. doi:10.1038/nature07488 18978773
Licatalosi DD , Yano M , Fak JJ , Mele A , Grabinski SE , Zhang C , &amp; Darnell RB (2012). Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain. Genes &amp; Development, 26 (14 ), 1626–1642. doi:10.1101/gad.191338.112 22802532
Lilleväli K , Kulla A , &amp; Örd T (2001). Comparative expression analysis of the genes encoding polypyrimidine tract binding protein (PTB) and its neural homologue (brPTB) in prenatal and postnatal mouse brain. Mechanisms of Development, 101 (1 ), 217–220. doi:10.1016/S0925-4773(00)00566-9 11231079
Lin B , Rommens JM , Graham RK , Kalchman M , MacDonald H , Nasir J , . . . Hayden MR . (1993). Differential 3′ polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression. Human Molecular Genetics, 2 (10 ), 1541–1545. doi:10.1093/hmg/2.10.1541 7903579
Lin C-LG , Bristol LA , Jin L , Dykes-Hoberg M , Crawford T , Clawson L , &amp; Rothstein JD (1998). Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis. Neuron, 20 (3 ), 589–602. doi:10.1016/S0896-6273(00)80997-6 9539131
Lin L , Park JW , Ramachandran S , Zhang Y , Tseng Y-T , Shen S , . . . Xing Y . (2016). Transcriptome sequencing reveals aberrant alternative splicing in Huntington’s disease. Human Molecular Genetics, 25 (16 ), 3454–3466. doi:10.1093/hmg/ddw187 27378699
Lin L , Zhang M , Stoilov P , Chen L , &amp; Zheng S (2020). Developmental Attenuation of Neuronal Apoptosis by Neural-Specific Splicing of Bak1 Microexon. Neuron, 107 (6 ), 1180–1196.e1188. doi:10.1016/j.neuron.2020.06.036 32710818
Lipinski Marta M , Zheng B , Lu T , Yan Z , Py Bénédicte F , Ng A , . . . Yuan J . (2010). Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer’s disease. Proceedings of the National Academy of Sciences, 107 (32 ), 14164–14169. doi:10.1073/pnas.1009485107
Liu Q , Greimann JC , &amp; Lima CD (2006). Reconstitution, Activities, and Structure of the Eukaryotic RNA Exosome. Cell, 127 (6 ), 1223–1237. doi:10.1016/j.cell.2006.10.037 17174896
Liu X , Bates R , Yin D-M , Shen C , Wang F , Su N , . . . Mei L . (2011). Specific Regulation of NRG1 Isoform Expression by Neuronal Activity. The Journal of Neuroscience, 31 (23 ), 8491. doi:10.1523/JNEUROSCI.5317-10.2011 21653853
Liu-Yesucevitz L , Bilgutay A , Zhang Y-J , Vanderwyde T , Citro A , Mehta T , . . . Wolozin B . (2010). Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue. PLOS ONE, 5 (10 ), e13250. doi:10.1371/journal.pone.0013250 20948999
Llorian M , Schwartz S , Clark TA , Hollander D , Tan L-Y , Spellman R , . . . Smith CWJ . (2010). Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nature Structural &amp; Molecular Biology, 17 (9 ), 1114–1123. doi:10.1038/nsmb.1881
Loerch PM , Lu T , Dakin KA , Vann JM , Isaacs A , Geula C , . . . Yankner BA . (2008). Evolution of the Aging Brain Transcriptome and Synaptic Regulation. PLOS ONE, 3 (10 ), e3329. doi:10.1371/journal.pone.0003329 18830410
Lu B , Wang KH , &amp; Nose A (2009). Molecular mechanisms underlying neural circuit formation. Current Opinion in Neurobiology, 19 (2 ), 162–167. doi:10.1016/j.conb.2009.04.004 19457653
Lu T , Pan Y , Kao S-Y , Li C , Kohane I , Chan J , &amp; Yankner BA (2004). Gene regulation and DNA damage in the ageing human brain. Nature, 429 (6994 ), 883–891. doi:10.1038/nature02661 15190254
Lukacsovich D , Winterer J , Que L , Luo W , Lukacsovich T , &amp; Földy C (2019). Single-Cell RNA-Seq Reveals Developmental Origins and Ontogenetic Stability of Neurexin Alternative Splicing Profiles. Cell Reports, 27 (13 ), 3752–3759.e3754. doi:10.1016/j.celrep.2019.05.090 31242409
Lukáš Z , Falk M , Feit J , Souček O , Falková I , Štefančíková L , . . . Hrabálková R . (2012). Sequestration of MBNL1 in tissues of patients with myotonic dystrophy type 2. Neuromuscular Disorders, 22 (7 ), 604–616. doi:10.1016/j.nmd.2012.03.004 22520280
Lunkes A , Lindenberg KS , Ben-Haïem L , Weber C , Devys D , Landwehrmeyer GB , . . . Trottier Y (2002). Proteases Acting on Mutant Huntingtin Generate Cleaved Products that Differentially Build Up Cytoplasmic and Nuclear Inclusions. Molecular Cell, 10 (2 ), 259–269. doi:10.1016/S1097-2765(02)00602-0 12191472
Majoros WH , &amp; Ohler U (2007). Spatial preferences of microRNA targets in 3’ untranslated regions. BMC Genomics, 8 (1 ), 152. doi:10.1186/1471-2164-8-152 17555584
Makeyev EV , Zhang J , Carrasco MA , &amp; Maniatis T (2007). The MicroRNA miR-124 Promotes Neuronal Differentiation by Triggering Brain-Specific Alternative Pre-mRNA Splicing. Molecular Cell, 27 (3 ), 435–448. doi:10.1016/j.molcel.2007.07.015 17679093
Mansfield KD , &amp; Keene JD (2012). Neuron-specific ELAV/Hu proteins suppress HuR mRNA during neuronal differentiation by alternative polyadenylation. Nucleic Acids Research, 40 (6 ), 2734–2746. doi:10.1093/nar/gkr1114 22139917
Marques-Coelho D , Iohan L. d. C. C. , Melo de Farias AR , Flaig A , Letournel F , Martin-Négrier M-L , . . . The Brainbank Neuro–, C. E. B. N. N. (2021). Differential transcript usage unravels gene expression alterations in Alzheimer’s disease human brains. npj Aging and Mechanisms of Disease, 7 (1 ), 2. doi:10.1038/s41514-020-00052-5 33398016
Martin I (2016). Decoding Parkinson’s Disease Pathogenesis: The Role of Deregulated mRNA Translation. Journal of Parkinson’s Disease, 6 , 17–27. doi:10.3233/JPD-150738
Masamha CP , Xia Z , Yang J , Albrecht TR , Li M , Shyu A-B , . . . Wagner EJ . (2014). CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature, 510 (7505 ), 412–416. doi:10.1038/nature13261 24814343
Maslon MM , Braunschweig U , Aitken S , Mann AR , Kilanowski F , Hunter CJ , . . . Cáceres JF . (2019). A slow transcription rate causes embryonic lethality and perturbs kinetic coupling of neuronal genes. The EMBO Journal, 38 (9 ), e101244. doi:10.15252/embj.2018101244 30988016
Mattioli CC , Rom A , Franke V , Imami K , Arrey G , Terne M , . . . Chekulaeva M . (2019). Alternative 3′ UTRs direct localization of functionally diverse protein isoforms in neuronal compartments. Nucleic Acids Research, 47 (5 ), 2560–2573. doi:10.1093/nar/gky1270 30590745
Mayr C , &amp; Bartel DP (2009). Widespread Shortening of 3’ UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells. Cell, 138 (4 ), 673–684. doi:10.1016/j.cell.2009.06.016 19703394
Mecocci P , MacGarvey U , Kaufman AE , Koontz D , Shoffner JM , Wallace DC , &amp; Beal MF (1993). Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Annals of Neurology, 34 (4 ), 609–616. doi:10.1002/ana.410340416 8215249
Melamed Z. e. , López-Erauskin J , Baughn MW , Zhang O , Drenner K , Sun Y , . . . Cleveland DW . (2019). Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nature Neuroscience, 22 (2 ), 180–190. doi:10.1038/s41593-018-0293-z 30643298
Merkin J , Russell C , Chen P , &amp; Burge Christopher B (2012). Evolutionary Dynamics of Gene and Isoform Regulation in Mammalian Tissues. Science, 338 (6114 ), 1593–1599. doi:10.1126/science.1228186 23258891
Migliore M , &amp; Shepherd GM (2005). An integrated approach to classifying neuronal phenotypes. Nature Reviews Neuroscience, 6 (10 ), 810–818. doi:10.1038/nrn1769 16276357
Minis A , Dahary D , Manor O , Leshkowitz D , Pilpel Y , &amp; Yaron A (2014). Subcellular transcriptomics—Dissection of the mRNA composition in the axonal compartment of sensory neurons. Developmental Neurobiology, 74 (3 ), 365–381. doi:10.1002/dneu.22140 24127433
Mirisis AA , &amp; Carew TJ (2019). The ELAV family of RNA-binding proteins in synaptic plasticity and long-term memory. Neurobiology of Learning and Memory, 161 , 143–148. doi:10.1016/j.nlm.2019.04.007 30998973
Mitchell P , Petfalski E , Shevchenko A , Mann M , &amp; Tollervey D (1997). The Exosome: A Conserved Eukaryotic RNA Processing Complex Containing Multiple 3′→5′ Exoribonucleases. Cell, 91 (4 ), 457–466. doi:10.1016/S0092-8674(00)80432-8 9390555
Miura P , Shenker S , Andreu-Agullo C , Westholm JO , &amp; Lai EC (2013). Widespread and extensive lengthening of 3′ UTRs in the mammalian brain. Genome Research, 23 (5 ), 812–825. doi:10.1101/gr.146886.112 23520388
Mnatzakanian GN , Lohi H , Munteanu I , Alfred SE , Yamada T , MacLeod PJM , . . . Minassian BA . (2004). A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nature Genetics, 36 (4 ), 339–341. doi:10.1038/ng1327 15034579
Molyneaux BJ , Arlotta P , Menezes JRL , &amp; Macklis JD (2007). Neuronal subtype specification in the cerebral cortex. Nature Reviews Neuroscience, 8 (6 ), 427–437. doi:10.1038/nrn2151 17514196
Monaghan CE , Adamson SI , Kapur M , Chuang JH , &amp; Ackerman SL (2021). The Clp1 R140H mutation alters tRNA metabolism and mRNA 3′ processing in mouse models of pontocerebellar hypoplasia. Proceedings of the National Academy of Sciences, 118 (39 ), e2110730118. doi:10.1073/pnas.2110730118
Moretti P , &amp; Zoghbi HY (2006). MeCP2 dysfunction in Rett syndrome and related disorders. Current Opinion in Genetics &amp; Development, 16 (3 ), 276–281. doi:10.1016/j.gde.2006.04.009 16647848
Morrison BM , Hof PR , &amp; Morrison JH (1998). Determinants of neuronal vulnerability in neurodegenerative diseases. Annals of Neurology, 44 (S1 ), S32–S44. doi:10.1002/ana.410440706 9749571
Mort M , Carlisle FA , Waite AJ , Elliston L , Allen ND , Jones L , &amp; Hughes AC (2015). Huntingtin Exists as Multiple Splice Forms in Human Brain. Journal of Huntington’s Disease, 4 , 161–171. doi:10.3233/JHD-150151
Morton DJ , Kuiper EG , Jones SK , Leung SW , Corbett AH , &amp; Fasken MB (2018). The RNA exosome and RNA exosome-linked disease. RNA, 24 (2 ), 127–142. doi:10.1261/rna.064626.117 29093021
Moss J , &amp; Howlin P (2009). Autism spectrum disorders in genetic syndromes: implications for diagnosis, intervention and understanding the wider autism spectrum disorder population. Journal of Intellectual Disability Research, 53 (10 ), 852–873. doi:10.1111/j.1365-2788.2009.01197.x 19708861
Mountoufaris G , Chen Weisheng V , Hirabayashi Y , O’Keeffe S , Chevee M , Nwakeze Chiamaka L , . . . Maniatis T (2017). Multicluster Pcdh diversity is required for mouse olfactory neural circuit assembly. Science, 356 (6336 ), 411–414. doi:10.1126/science.aai8801 28450637
Mukherjee N , Corcoran David L. , Nusbaum Jeffrey D. , Reid David W. , Georgiev S , Hafner M , . . . Keene Jack D . (2011). Integrative Regulatory Mapping Indicates that the RNA-Binding Protein HuR Couples Pre-mRNA Processing and mRNA Stability. Molecular Cell, 43 (3 ), 327–339. doi:10.1016/j.molcel.2011.06.007 21723170
Müller JS , Burns DT , Griffin H , Wells GR , Zendah RA , Munro B , . . . Horvath R . (2020). RNA exosome mutations in pontocerebellar hypoplasia alter ribosome biogenesis and p53 levels. Life Science Alliance, 3 (8 ), e202000678. doi:10.26508/lsa.202000678 32527837
Mykowska A , Sobczak K , Wojciechowska M , Kozlowski P , &amp; Krzyzosiak WJ (2011). CAG repeats mimic CUG repeats in the misregulation of alternative splicing. Nucleic Acids Research, 39 (20 ), 8938–8951. doi:10.1093/nar/gkr608 21795378
Nagy G , Milosevic I , Fasshauer D , Müller EM , de Groot BL , Lang T , . . . Sørensen JB . (2005). Alternative Splicing of SNAP-25 Regulates Secretion through Nonconservative Substitutions in the SNARE Domain. Molecular Biology of the Cell, 16 (12 ), 5675–5685. doi:10.1091/mbc.e05-07-0595 16195346
Nakahata S , &amp; Kawamoto S (2005). Tissue-dependent isoforms of mammalian Fox-1 homologs are associated with tissue-specific splicing activities. Nucleic Acids Research, 33 (7 ), 2078–2089. doi:10.1093/nar/gki338 15824060
Nam J-W , Rissland Olivia S. , Koppstein D , Abreu-Goodger C , Jan Calvin H. , Agarwal V , . . . Bartel David P . (2014). Global Analyses of the Effect of Different Cellular Contexts on MicroRNA Targeting. Molecular Cell, 53 (6 ), 1031–1043. doi:10.1016/j.molcel.2014.02.013 24631284
Nance MA , &amp; Myers RH (2001). Juvenile onset Huntington’s disease—clinical and research perspectives. Mental Retardation and Developmental Disabilities Research Reviews, 7 (3 ), 153–157. doi:10.1002/mrdd.1022 11553930
Neumann M , Sampathu Deepak M , Kwong Linda K , Truax Adam C , Micsenyi Matthew C , Chou Thomas T , . . . Lee Virginia MY . (2006). Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Science, 314 (5796 ), 130–133. doi:10.1126/science.1134108 17023659
Nguyen L , Rigo J-M , Rocher V , Belachew S , Malgrange B , Rogister B , . . . Moonen G . (2001). Neurotransmitters as early signals for central nervous system development. Cell and Tissue Research, 305 (2 ), 187–202. doi:10.1007/s004410000343 11545256
Nguyen LS , Jolly L , Shoubridge C , Chan WK , Huang L , Laumonnier F , . . . Gecz J . (2012). Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability. Molecular Psychiatry, 17 (11 ), 1103–1115. doi:10.1038/mp.2011.163 22182939
Nguyen T-M , Schreiner D , Xiao L , Traunmüller L , Bornmann C , &amp; Scheiffele P (2016). An alternative splicing switch shapes neurexin repertoires in principal neurons versus interneurons in the mouse hippocampus. eLife, 5 , e22757. doi:10.7554/eLife.22757 27960072
Nguyen-Ba-Charvet KT , &amp; Rebsam A (2020). Neurogenesis and Specification of Retinal Ganglion Cells. International Journal of Molecular Sciences, 21 (2 ). doi:10.3390/ijms21020451
Nunomura A , Moreira PI , Castellani RJ , Lee H. g. , Zhu X , Smith MA , &amp; Perry G (2012). Oxidative Damage to RNA in Aging and Neurodegenerative Disorders. Neurotoxicity Research, 22 (3 ), 231–248. doi:10.1007/s12640-012-9331-x 22669748
Ogawa Y , Yamaguchi J , Yano M , Uchiyama Y , &amp; Okano HJ (2018). Elavl3 regulates neuronal polarity through the alternative splicing of an embryo-specific exon in AnkyrinG. Neuroscience Research, 135 , 13–20. doi:10.1016/j.neures.2018.03.008 29614249
Ogorodnikov A , Levin M , Tattikota S , Tokalov S , Hoque M , Scherzinger D , . . . Danckwardt S . (2018). Transcriptome 3′end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma. Nature Communications, 9 (1 ), 5331. doi:10.1038/s41467-018-07580-5
Okano HJ , &amp; Darnell RB (1997). A Hierarchy of Hu RNA Binding Proteins in Developing and Adult Neurons. The Journal of Neuroscience, 17 (9 ), 3024. doi:10.1523/JNEUROSCI.17-09-03024.1997 9096138
Oku S , Feng H , Connor S , Toledo A , Zhang P , Zhang Y , . . . Craig AM . (2020). Alternative splicing at neuroligin site A regulates glycan interaction and synaptogenic activity. eLife, 9 , e58668. doi:10.7554/eLife.58668 32915137
Oldham MC , Konopka G , Iwamoto K , Langfelder P , Kato T , Horvath S , &amp; Geschwind DH (2008). Functional organization of the transcriptome in human brain. Nature Neuroscience, 11 (11 ), 1271–1282. doi:10.1038/nn.2207 18849986
Osenberg S , Karten A , Sun J , Li J , Charkowick S , Felice Christy A , . . . Ballas N . (2018). Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome. Proceedings of the National Academy of Sciences, 115 (23 ), E5363–E5372. doi:10.1073/pnas.1722546115
Ou SH , Wu F , Harrich D , García-Martínez LF , &amp; Gaynor RB (1995). Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. Journal of Virology, 69 (6 ), 3584–3596. doi:10.1128/jvi.69.6.3584-3596.1995 7745706
Pacheco NL , Heaven MR , Holt LM , Crossman DK , Boggio KJ , Shaffer SA , . . . Olsen ML . (2017). RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome. Molecular Autism, 8 (1 ), 56. doi:10.1186/s13229-017-0174-4 29090078
Pakkenberg B , &amp; Gundersen HJG (1997). Neocortical neuron number in humans: Effect of sex and age. Journal of Comparative Neurology, 384 (2 ), 312–320. doi:10.1002/(SICI)1096-9861(19970728)384:2&lt;312::AID-CNE10&gt;3.0.CO;2-K 9215725
Pan Q , Shai O , Lee LJ , Frey BJ , &amp; Blencowe BJ (2008). Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature Genetics, 40 (12 ), 1413–1415. doi:10.1038/ng.259 18978789
Pan Y , &amp; Monje M (2020). Activity Shapes Neural Circuit Form and Function: A Historical Perspective. The Journal of Neuroscience, 40 (5 ), 944. doi:10.1523/JNEUROSCI.0740-19.2019 31996470
Paradies MA , &amp; Steward O (1997). Multiple subcellular mRNA distribution patterns in neurons: A nonisotopic in situ hybridization analysis. Journal of Neurobiology, 33 (4 ), 473–493. doi:10.1002/(SICI)1097-4695(199710)33:4&lt;473::AID-NEU10&gt;3.0.CO;2-D 9322162
Park M , &amp; Shen K (2012). WNTs in synapse formation and neuronal circuitry. The EMBO Journal, 31 (12 ), 2697–2704. doi:10.1038/emboj.2012.145 22617419
Pascale A , Amadio M , Scapagnini G , Lanni C , Racchi M , Provenzani A , . . . Quattrone A . (2005). Neuronal ELAV proteins enhance mRNA stability by a PKCα-dependent pathway. Proceedings of the National Academy of Sciences, 102 (34 ), 12065–12070. doi:10.1073/pnas.0504702102
Patel H , Hodges AK , Curtis C , Lee SH , Troakes C , Dobson RJB , &amp; Newhouse SJ (2019). Transcriptomic analysis of probable asymptomatic and symptomatic alzheimer brains. Brain, Behavior, and Immunity, 80 , 644–656. doi:10.1016/j.bbi.2019.05.009 31063847
Penn Andrew C. , Balik A , Wozny C , Cais O , &amp; Greger Ingo H . (2012). Activity-Mediated AMPA Receptor Remodeling, Driven by Alternative Splicing in the Ligand-Binding Domain. Neuron, 76 (3 ), 503–510. doi:10.1016/j.neuron.2012.08.010 23141062
Petazzi P , Sandoval J , Szczesna K , Jorge OC , Roa L , Sayols S , . . . Esteller M . (2013). Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model. RNA Biology, 10 (7 ), 1197–1203. doi:10.4161/rna.24286 23611944
Phillips GR , Tanaka H , Frank M , Elste A , Fidler L , Benson DL , &amp; Colman DR (2003). γ-Protocadherins Are Targeted to Subsets of Synapses and Intracellular Organelles in Neurons. The Journal of Neuroscience, 23 (12 ), 5096. doi:10.1523/JNEUROSCI.23-12-05096.2003 12832533
Poirier K , Hubert L , Viot G , Rio M , Billuart P , Besmond C , &amp; Bienvenu T (2017). CSNK2B splice site mutations in patients cause intellectual disability with or without myoclonic epilepsy. Human Mutation, 38 (8 ), 932–941. doi:10.1002/humu.23270 28585349
Polymenidou M , Lagier-Tourenne C , Hutt KR , Huelga SC , Moran J , Liang TY , . . . Cleveland DW . (2011). Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nature Neuroscience, 14 (4 ), 459–468. doi:10.1038/nn.2779 21358643
Purcell AE , Jeon OH , Zimmerman AW , Blue ME , &amp; Pevsner J (2001). Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology, 57 (9 ), 1618. doi:10.1212/WNL.57.9.1618 11706102
Quesnel-Vallières M , Weatheritt RJ , Cordes SP , &amp; Blencowe BJ (2019). Autism spectrum disorder: insights into convergent mechanisms from transcriptomics. Nature Reviews Genetics, 20 (1 ), 51–63. doi:10.1038/s41576-018-0066-2
Raj T , Li YI , Wong G , Humphrey J , Wang M , Ramdhani S , . . . De Jager PL . (2018). Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer’s disease susceptibility. Nature Genetics, 50 (11 ), 1584–1592. doi:10.1038/s41588-018-0238-1 30297968
Rajgor D , Welle TM , &amp; Smith KR (2021). The Coordination of Local Translation, Membranous Organelle Trafficking, and Synaptic Plasticity in Neurons. Frontiers in Cell and Developmental Biology, 9 . doi:10.3389/fcell.2021.711446
Ramsköld D , Wang ET , Burge CB , &amp; Sandberg R (2009). An Abundance of Ubiquitously Expressed Genes Revealed by Tissue Transcriptome Sequence Data. PLOS Computational Biology, 5 (12 ), e1000598. doi:10.1371/journal.pcbi.1000598 20011106
Ratti A , &amp; Buratti E (2016). Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. Journal of Neurochemistry, 138 (S1 ), 95–111. doi:10.1111/jnc.13625 27015757
Reichert SC , Li R , Turner A , S. , van Jaarsveld RH , Massink MPG , van den Boogaard M-JH , . . . Lewandowski R (2020). HNRNPH1-related syndromic intellectual disability: Seven additional cases suggestive of a distinct syndromic neurodevelopmental syndrome. Clinical Genetics, 98 (1 ), 91–98. doi:10.1111/cge.13765 32335897
Resnick M , Segall A , G GR-K , Lupowitz Z , &amp; Zisapel N . (2008). Alternative splicing of neurexins: A role for neuronal polypyrimidine tract binding protein. Neuroscience Letters, 439 (3 ), 235–240. doi:10.1016/j.neulet.2008.05.034 18534753
Reyes A , &amp; Huber W (2018). Alternative start and termination sites of transcription drive most transcript isoform differences across human tissues. Nucleic Acids Research, 46 (2 ), 582–592. doi:10.1093/nar/gkx1165 29202200
Rhinn H , Qiang L , Yamashita T , Rhee D , Zolin A , Vanti W , &amp; Abeliovich A (2012). Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson’s disease pathology. Nature Communications, 3 (1 ), 1084. doi:10.1038/ncomms2032
Richter JD , &amp; Klann E (2009). Making synaptic plasticity and memory last: mechanisms of translational regulation. Genes &amp; Development, 23 (1 ), 1–11. doi:10.1101/gad.1735809 19136621
Ritchie DB , Schellenberg MJ , &amp; MacMillan AM (2009). Spliceosome structure: Piece by piece. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1789 (9 ), 624–633. doi:10.1016/j.bbagrm.2009.08.010 19733268
Rodrigues Deivid C. , Kim D-S , Yang G , Zaslavsky K , Ha KCH Mok Rebecca S. F. , . . . Ellis J . (2016). MECP2 Is Post-transcriptionally Regulated during Human Neurodevelopment by Combinatorial Action of RNA-Binding Proteins and miRNAs. Cell Reports, 17 (3 ), 720–734. doi:10.1016/j.celrep.2016.09.049 27732849
Romo L , Ashar-Patel A , Pfister E , &amp; Aronin N (2017). Alterations in mRNA 3’ UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington’s Disease Brains. Cell Reports, 20 (13 ), 3057–3070. doi:10.1016/j.celrep.2017.09.009 28954224
Rubenstein JLR , &amp; Merzenich MM (2003). Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes, Brain and Behavior, 2 (5 ), 255–267. doi:10.1034/j.1601-183X.2003.00037.x 14606691
Rubinstein R , Thu Chan A. , Goodman Kerry M. , Wolcott Holly N. , Bahna F , Mannepalli S , . . . Honig B (2015). Molecular Logic of Neuronal Self-Recognition through Protocadherin Domain Interactions. Cell, 163 (3 ), 629–642. doi:10.1016/j.cell.2015.09.026 26478182
Rudnik-Schöneborn S , Senderek J , Jen JC , Houge G , Seeman P , Puchmajerová A , . . . Zerres K . (2013). Pontocerebellar hypoplasia type 1. Neurology, 80 (5 ), 438. doi:10.1212/WNL.0b013e31827f0f66 23284067
Russ DE , Cross RBP , Li L , Koch SC , Matson KJE , Yadav A , . . . Levine AJ . (2021). A harmonized atlas of mouse spinal cord cell types and their spatial organization. Nature Communications, 12 (1 ), 5722. doi:10.1038/s41467-021-25125-1
Ruzo A , Ismailoglu I , Popowski M , Haremaki T , Croft GF , Deglincerti A , &amp; Brivanlou AH (2015). Discovery of Novel Isoforms of Huntingtin Reveals a New Hominid-Specific Exon. PLOS ONE, 10 (5 ), e0127687. doi:10.1371/journal.pone.0127687 26010866
Rybak-Wolf A , &amp; Plass M (2021). RNA Dynamics in Alzheimer’s Disease. Molecules, 26 (17 ). doi:10.3390/molecules26175113
Saito Y , Miranda-Rottmann S , Ruggiu M , Park CY , Fak JJ , Zhong R , . . . Darnell RB . (2016). NOVA2-mediated RNA regulation is required for axonal pathfinding during development. eLife, 5 , e14371. doi:10.7554/eLife.14371 27223325
Sandberg R , Neilson Joel R , Sarma A , Sharp Phillip A , &amp; Burge Christopher B (2008). Proliferating Cells Express mRNAs with Shortened 3’ Untranslated Regions and Fewer MicroRNA Target Sites. Science, 320 (5883 ), 1643–1647. doi:10.1126/science.1155390 18566288
Sato N , Hori O , Yamaguchi A , Lambert J-C , Chartier-Harlin M-C , Robinson PA , . . . Takagi T . (1999). A Novel Presenilin-2 Splice Variant in Human Alzheimer’s Disease Brain Tissue. Journal of Neurochemistry, 72 (6 ), 2498–2505. doi:10.1046/j.1471-4159.1999.0722498.x 10349860
Saunders A , Macosko EZ , Wysoker A , Goldman M , Krienen FM , de Rivera H , . . . McCarroll SA . (2018). Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain. Cell, 174 (4 ), 1015–1030.e1016. doi:10.1016/j.cell.2018.07.028 30096299
Sawicka K , Bushell M , Spriggs Keith A. , &amp; Willis Anne E. (2008). Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein. Biochemical Society Transactions, 36 (4 ), 641–647. doi:10.1042/BST0360641 18631133
Saxena S , &amp; Caroni P (2011). Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration. Neuron, 71 (1 ), 35–48. doi:10.1016/j.neuron.2011.06.031 21745636
Schaffer Ashleigh E. , Eggens Veerle R. C. , Caglayan Ahmet O. , Reuter Miriam S. , Scott E , Coufal Nicole G. , . . . Gleeson Joseph G . (2014). CLP1 Founder Mutation Links tRNA Splicing and Maturation to Cerebellar Development and Neurodegeneration. Cell, 157 (3 ), 651–663. doi:10.1016/j.cell.2014.03.049 24766810
Schilling J , Broemer M , Atanassov I , Duernberger Y , Vorberg I , Dieterich C , . . . Krauß S . (2019). Deregulated Splicing Is a Major Mechanism of RNA-Induced Toxicity in Huntington’s Disease. Journal of Molecular Biology, 431 (9 ), 1869–1877. doi:10.1016/j.jmb.2019.01.034 30711541
Schreiner D , Nguyen T-M , Russo G , Heber S , Patrignani A , Ahrné E , &amp; Scheiffele P (2014). Targeted Combinatorial Alternative Splicing Generates Brain Region-Specific Repertoires of Neurexins. Neuron, 84 (2 ), 386–398. doi:10.1016/j.neuron.2014.09.011 25284007
Schreiner D , &amp; Weiner Joshua A (2010). Combinatorial homophilic interaction between γ-protocadherin multimers greatly expands the molecular diversity of cell adhesion. Proceedings of the National Academy of Sciences, 107 (33 ), 14893–14898. doi:10.1073/pnas.1004526107
Schulze M , Sommer A , Plötz S , Farrell M , Winner B , Grosch J , . . . Riemenschneider MJ . (2018). Sporadic Parkinson’s disease derived neuronal cells show disease-specific mRNA and small RNA signatures with abundant deregulation of piRNAs. Acta Neuropathologica Communications, 6 (1 ), 58. doi:10.1186/s40478-018-0561-x 29986767
Sellier C , Cerro-Herreros E , Blatter M , Freyermuth F , Gaucherot A , Ruffenach F , . . . Charlet-Berguerand N . (2018). rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences. Nature Communications, 9 (1 ), 2009. doi:10.1038/s41467-018-04370-x
Senzaki K , Ogawa M , &amp; Yagi T (1999). Proteins of the CNR Family Are Multiple Receptors for Reelin. Cell, 99 (6 ), 635–647. doi:10.1016/S0092-8674(00)81552-4 10612399
Shahbazian MD , Antalffy B , Armstrong DL , &amp; Zoghbi HY (2002). Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Human Molecular Genetics, 11 (2 ), 115–124. doi:10.1093/hmg/11.2.115 11809720
Shepard PJ , Choi E-A , Lu J , Flanagan LA , Hertel KJ , &amp; Shi Y (2011). Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq. RNA, 17 (4 ), 761–772. doi:10.1261/rna.2581711 21343387
Shi Y , Di Giammartino DC , Taylor D , Sarkeshik A , Rice WJ , Yates JR III , . . . Manley JL (2009). Molecular Architecture of the Human Pre-mRNA 3’ Processing Complex. Molecular Cell, 33 (3 ), 365–376. doi:10.1016/j.molcel.2008.12.028 19217410
Shulman ED , &amp; Elkon R (2019). Cell-type-specific analysis of alternative polyadenylation using single-cell transcriptomics data. Nucleic Acids Research, 47 (19 ), 10027–10039. doi:10.1093/nar/gkz781 31501864
Siddique N , &amp; Siddique T (2001 [Updated 2021]). Amyotrophic Lateral Sclerosis Overview. In Adam MP , Ardinger HH , &amp; Pagon RA (Eds.), GeneReviews [Internet]. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK1450/
Silbereis John C. , Pochareddy S , Zhu Y , Li M , &amp; Sestan N (2016). The Cellular and Molecular Landscapes of the Developing Human Central Nervous System. Neuron, 89 (2 ), 248–268. doi:10.1016/j.neuron.2015.12.008 26796689
Simon DK , Tanner CM , &amp; Brundin P (2020). Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clinics in Geriatric Medicine, 36 (1 ), 1–12. doi:10.1016/j.cger.2019.08.002 31733690
Singh P , Alley TL , Wright SM , Kamdar S , Schott W , Wilpan RY , . . . Graber JH (2009). Global Changes in Processing of mRNA 3′ Untranslated Regions Characterize Clinically Distinct Cancer Subtypes. Cancer Research, 69 (24 ), 9422–9430. doi:10.1158/0008-5472.CAN-09-2236 19934316
Snell RG , MacMillan JC , Cheadle JP , Fenton I , Lazarou LP , Davies P , . . . Shaw DJ (1993). Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington’s disease. Nature Genetics, 4 (4 ), 393–397. doi:10.1038/ng0893-393 8401588
Somel M , Guo S , Fu N , Yan Z , Hu HY , Xu Y , . . . Khaitovich P (2010). MicroRNA, mRNA, and protein expression link development and aging in human and macaque brain. Genome Research, 20 (9 ), 1207–1218. doi:10.1101/gr.106849.110 20647238
Sommer B , Keinänen K , Verdoorn Todd A , Wisden W , Burnashev N , Herb A , . . . Seeburg Peter H (1990). Flip and Flop: A Cell-Specific Functional Switch in Glutamate-Operated Channels of the CNS. Science, 249 (4976 ), 1580–1585. doi:10.1126/science.1699275 1699275
Song Y , Botvinnik OB , Lovci MT , Kakaradov B , Liu P , Xu JL , &amp; Yeo GW (2017). Single-Cell Alternative Splicing Analysis with Expedition Reveals Splicing Dynamics during Neuron Differentiation. Molecular Cell, 67 (1 ), 148–161.e145. doi:10.1016/j.molcel.2017.06.003 28673540
Sousa AMM , Meyer KA , Santpere G , Gulden FO , &amp; Sestan N (2017). Evolution of the Human Nervous System Function, Structure, and Development. Cell, 170 (2 ), 226–247. doi:10.1016/j.cell.2017.06.036 28708995
Spellman R , Llorian M , &amp; Smith CWJ (2007). Crossregulation and Functional Redundancy between the Splicing Regulator PTB and Its Paralogs nPTB and ROD1. Molecular Cell, 27 (3 ), 420–434. doi:10.1016/j.molcel.2007.06.016 17679092
Spies N , Burge CB , &amp; Bartel DP (2013). 3′ UTR-isoform choice has limited influence on the stability and translational efficiency of most mRNAs in mouse fibroblasts. Genome Research, 23 (12 ), 2078–2090. doi:10.1101/gr.156919.113 24072873
Sreedharan J , Blair IP , Tripathi VB , Hu X , Vance C , Rogelj B , . . . Shaw CE . (2008). TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science, 319 (5870 ), 1668–1672. doi:10.1126/science.1154584 18309045
Stark A , Brennecke J , Bushati N , Russell RB , &amp; Cohen SM (2005). Animal MicroRNAs Confer Robustness to Gene Expression and Have a Significant Impact on 3’ UTR Evolution. Cell, 123 (6 ), 1133–1146. doi:10.1016/j.cell.2005.11.023 16337999
Stegeman R , &amp; Weake VM (2017). Transcriptional Signatures of Aging. Journal of Molecular Biology, 429 (16 ), 2427–2437. doi:10.1016/j.jmb.2017.06.019 28684248
Su C-H , D D , &amp; Tarn W-Y (2018). Alternative Splicing in Neurogenesis and Brain Development. Frontiers in Molecular Biosciences, 5 . doi:10.3389/fmolb.2018.00012
Sugino H , Hamada S , Yasuda R , Tuji A , Matsuda Y , Fujita M , &amp; Yagi T (2000). Genomic Organization of the Family of CNR Cadherin Genes in Mice and Humans. Genomics, 63 (1 ), 75–87. doi:10.1006/geno.1999.6066 10662547
Sugino K , Hempel CM , Okaty BW , Arnson HA , Kato S , Dani VS , &amp; Nelson SB (2014). Cell-Type-Specific Repression by Methyl-CpG-Binding Protein 2 Is Biased toward Long Genes. The Journal of Neuroscience, 34 (38 ), 12877. doi:10.1523/JNEUROSCI.2674-14.2014 25232122
Sun Y , Hamilton K , &amp; Tong L (2020). Recent molecular insights into canonical pre-mRNA 3’-end processing. Transcription, 11 (2 ), 83–96. doi:10.1080/21541264.2020.1777047 32522085
Sun Y-F , Yu L-Y , Saarma M , Timmusk T , &amp; Arumäe U (2001). Neuron-specific Bcl-2 Homology 3 Domain-only Splice Variant of Bak Is Anti-apoptotic in Neurons, but Pro-apoptotic in Non-neuronal Cells*. Journal of Biological Chemistry, 276 (19 ), 16240–16247. doi:10.1074/jbc.M010419200 11278671
Suo L , Lu H , Ying G , Capecchi MR , &amp; Wu Q (2012). Protocadherin clusters and cell adhesion kinase regulate dendrite complexity through Rho GTPase. Journal of Molecular Cell Biology, 4 (6 ), 362–376. doi:10.1093/jmcb/mjs034 22730554
Takarae Y , &amp; Sweeney J (2017). Neural Hyperexcitability in Autism Spectrum Disorders. Brain Sciences, 7 (10 ). doi:10.3390/brainsci7100129
Takeuchi A , Iida K , Tsubota T , Hosokawa M , Denawa M , Brown JB , . . . Hagiwara M (2018). Loss of Sfpq Causes Long-Gene Transcriptopathy in the Brain. Cell Reports, 23 (5 ), 1326–1341. doi:10.1016/j.celrep.2018.03.141 29719248
Taliaferro JM , Vidaki M , Oliveira R , Olson S , Zhan L , Saxena T , . . . Burge, Christopher B (2016). Distal Alternative Last Exons Localize mRNAs to Neural Projections. Molecular Cell, 61 (6 ), 821–833. doi:10.1016/j.molcel.2016.01.020 26907613
Tan EK , Shen H , Tan JMM , Lim KL , Fook-Chong S , Hu WP , . . . Zhao Y (2005). Differential expression of splice variant and wild-type parkin in sporadic Parkinson’s disease. Neurogenetics, 6 (4 ), 179–184. doi:10.1007/s10048-005-0001-5 16086186
Tanaka H , Grooms SY , Bennett MVL , &amp; Zukin RS (2000). The AMPAR subunit GluR2: still front and center-stage. Brain Research, 886 (1 ), 190–207. doi:10.1016/S0006-8993(00)02951-6 11119696
Tang Y , Nyengaard JR , De Groot DMG , &amp; Gundersen HJG (2001). Total regional and global number of synapses in the human brain neocortex. Synapse, 41 (3 ), 258–273. doi:10.1002/syn.1083 11418939
Tapial J , Ha KCH , Sterne-Weiler T , Gohr A , Braunschweig U , Hermoso-Pulido A , . . . Irimia M (2017). An atlas of alternative splicing profiles and functional associations reveals new regulatory programs and genes that simultaneously express multiple major isoforms. Genome Research, 27 (10 ), 1759–1768. doi:10.1101/gr.220962.117 28855263
Tasic B , Menon V , Nguyen TN , Kim TK , Jarsky T , Yao Z , . . . Zeng H (2016). Adult mouse cortical cell taxonomy revealed by single cell transcriptomics. Nature Neuroscience, 19 (2 ), 335–346. doi:10.1038/nn.4216 26727548
Tasic B , Nabholz CE , Baldwin KK , Kim Y , Rueckert EH , Ribich SA , . . . Maniatis T (2002). Promoter Choice Determines Splice Site Selection in Protocadherin α and γ Pre-mRNA Splicing. Molecular Cell, 10 (1 ), 21–33. doi:10.1016/S1097-2765(02)00578-6 12150904
Tassone F , De Rubeis S , Carosi C , La Fata G , Serpa G , Raske C , . . . Bagni C (2011). Differential usage of transcriptional start sites and polyadenylation sites in FMR1 premutation alleles. Nucleic Acids Research, 39 (14 ), 6172–6185. doi:10.1093/nar/gkr100 21478165
Tassone F , Iwahashi C , &amp; Hagerman PJ (2004). FMR1 RNA within the Intranuclear Inclusions of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS). RNA Biology, 1 (2 ), 103–105. doi:10.4161/rna.1.2.1035 17179750
Thalhammer A , Jaudon F , &amp; Cingolani LA (2020). Emerging Roles of Activity-Dependent Alternative Splicing in Homeostatic Plasticity. Frontiers in Cellular Neuroscience, 14 . doi:10.3389/fncel.2020.00104
Thurm A , Farmer C , Salzman E , Lord C , &amp; Bishop S (2019). State of the Field: Differentiating Intellectual Disability From Autism Spectrum Disorder. Frontiers in Psychiatry, 10 . doi:10.3389/fpsyt.2019.00526
Tian B , Hu J , Zhang H , &amp; Lutz CS (2005). A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Research, 33 (1 ), 201–212. doi:10.1093/nar/gki158 15647503
Tollervey JR , Curk T , Rogelj B , Briese M , Cereda M , Kayikci M , . . . Ule J (2011). Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nature Neuroscience, 14 (4 ), 452–458. doi:10.1038/nn.2778 21358640
Tollervey JR , Wang Z , Hortobágyi T , Witten JT , Zarnack K , Kayikci M , . . . Ule J (2011). Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. Genome Research, 21 (10 ), 1572–1582. doi:10.1101/gr.122226.111 21846794
Traunmüller L , Bornmann C , &amp; Scheiffele P (2014). Alternative Splicing Coupled Nonsense-Mediated Decay Generates Neuronal Cell Type-Specific Expression of SLM Proteins. The Journal of Neuroscience, 34 (50 ), 16755. doi:10.1523/JNEUROSCI.3395-14.2014 25505328
Traunmüller L , Gomez Andrea M , Nguyen T-M , &amp; Scheiffele P (2016). Control of neuronal synapse specification by a highly dedicated alternative splicing program. Science, 352 (6288 ), 982–986. doi:10.1126/science.aaf2397 27174676
Treutlein B , Gokce O , Quake SR , &amp; Südhof TC (2014). Cartography of neurexin alternative splicing mapped by single-molecule long-read mRNA sequencing. Proceedings of the National Academy of Sciences, 111 (13 ), E1291–E1299. doi:10.1073/pnas.1403244111
Tromp A , Mowry B , &amp; Giacomotto J (2021). Neurexins in autism and schizophrenia—a review of patient mutations, mouse models and potential future directions. Molecular Psychiatry, 26 (3 ), 747–760. doi:10.1038/s41380-020-00944-8 33191396
Trottier Y , Biancalana V , &amp; Mandel JL (1994). Instability of CAG repeats in Huntington’s disease: relation to parental transmission and age of onset. Journal of Medical Genetics, 31 (5 ), 377. doi:10.1136/jmg.31.5.377 8064815
Tushev G , Glock C , Heumüller M , Biever A , Jovanovic M , &amp; Schuman EM (2018). Alternative 3’ UTRs Modify the Localization, Regulatory Potential, Stability, and Plasticity of mRNAs in Neuronal Compartments. Neuron, 98 (3 ), 495–511.e496. doi:10.1016/j.neuron.2018.03.030 29656876
Twine NA , Janitz K , Wilkins MR , &amp; Janitz M (2011). Whole Transcriptome Sequencing Reveals Gene Expression and Splicing Differences in Brain Regions Affected by Alzheimer’s Disease. PLOS ONE, 6 (1 ), e16266. doi:10.1371/journal.pone.0016266 21283692
Ule J , Stefani G , Mele A , Ruggiu M , Wang X , Taneri B , . . . Darnell RB (2006). An RNA map predicting Nova-dependent splicing regulation. Nature, 444 (7119 ), 580–586. doi:10.1038/nature05304 17065982
Ule J , Ule A , Spencer J , Williams A , Hu J-S , Cline M , . . . Darnell RB (2005). Nova regulates brain-specific splicing to shape the synapse. Nature Genetics, 37 (8 ), 844–852. doi:10.1038/ng1610 16041372
Urreizti R , Lopez-Martin E , Martinez-Monseny A , Pujadas M , Castilla-Vallmanya L , Pérez-Jurado LA , . . . Balcells S (2020). Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrum. Orphanet Journal of Rare Diseases, 15 (1 ), 44. doi:10.1186/s13023-020-1317-9 32041641
Ushkaryov YA , &amp; Südhof TC (1993). Neurexin III alpha: extensive alternative splicing generates membrane-bound and soluble forms. Proceedings of the National Academy of Sciences, 90 (14 ), 6410–6414. doi:10.1073/pnas.90.14.6410
Van Deerlin VM , Leverenz JB , Bekris LM , Bird TD , Yuan W , Elman LB , . . . Yu C-E (2008). TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. The Lancet Neurology, 7 (5 ), 409–416. doi:10.1016/S1474-4422(08)70071-1 18396105
van der Feltz C , Anthony K , Brilot A , &amp; Pomeranz Krummel DA (2012). Architecture of the Spliceosome. Biochemistry, 51 (16 ), 3321–3333. doi:10.1021/bi201215r 22471593
van der Vaart B , van Riel Wilhelmina E. , Doodhi H , Kevenaar Josta T. , Katrukha Eugene A. , Gumy L , . . . Akhmanova A (2013). CFEOM1-Associated Kinesin KIF21A Is a Cortical Microtubule Growth Inhibitor. Developmental Cell, 27 (2 ), 145–160. doi:10.1016/j.devcel.2013.09.010 24120883
van Dijk T , Baas F , Barth PG , &amp; Poll-The BT (2018). What’s new in pontocerebellar hypoplasia? An update on genes and subtypes. Orphanet Journal of Rare Diseases, 13 (1 ), 92. doi:10.1186/s13023-018-0826-2 29903031
Vuong CK , Black DL , &amp; Zheng S (2016). The neurogenetics of alternative splicing. Nature Reviews Neuroscience, 17 (5 ), 265–281. doi:10.1038/nrn.2016.27 27094079
Vuong JK , Ergin V , Chen L , &amp; Zheng S (2022). Multilayered regulations of alternative splicing, NMD, and protein stability control temporal induction and tissue-specific expression of TRIM46 during axon formation. Nature Communications, 13 (1 ), 2081. doi:10.1038/s41467-022-29786-4
Vuong JK , Lin C-H , Zhang M , Chen L , Black DL , &amp; Zheng S (2016). PTBP1 and PTBP2 Serve Both Specific and Redundant Functions in Neuronal Pre-mRNA Splicing. Cell Reports, 17 (10 ), 2766–2775. doi:10.1016/j.celrep.2016.11.034 27926877
Wafik M , Taylor J , Lester T , Gibbons RJ , &amp; Shears DJ (2018). 2 new cases of pontocerebellar hypoplasia type 10 identified by whole exome sequencing in a Turkish family. European Journal of Medical Genetics, 61 (5 ), 273–279. doi:10.1016/j.ejmg.2018.01.002 29307788
Wan J , Yourshaw M , Mamsa H , Rudnik-Schöneborn S , Menezes MP , Hong JE , . . . Jen JC (2012). Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration. Nature Genetics, 44 (6 ), 704–708. doi:10.1038/ng.2254 22544365
Wang ET , Sandberg R , Luo S , Khrebtukova I , Zhang L , Mayr C , . . . Burge CB (2008). Alternative isoform regulation in human tissue transcriptomes. Nature, 456 (7221 ), 470–476. doi:10.1038/nature07509 18978772
Wang J , Zhang T , Yu Z , Tan WT , Wen M , Shen Y , . . . Wan Y (2021). Genome-wide RNA structure changes during human neurogenesis modulate gene regulatory networks. Molecular Cell, 81 (23 ), 4942–4953.e4948. doi:10.1016/j.molcel.2021.09.027 34655516
Wang Q , Moore MJ , Adelmant G , Marto JA , &amp; Silver PA (2013). PQBP1, a factor linked to intellectual disability, affects alternative splicing associated with neurite outgrowth. Genes &amp; Development, 27 (6 ), 615–626. doi:10.1101/gad.212308.112 23512658
Wang R , Zheng D , Yehia G , &amp; Tian B (2018). A compendium of conserved cleavage and polyadenylation events in mammalian genes. Genome Research, 28 (10 ), 1427–1441. doi:10.1101/gr.237826.118 30143597
Wang X , Su H , &amp; Bradley A (2002). Molecular mechanisms governing Pcdh-γ gene expression: Evidence for a multiple promoter and cis-alternative splicing model. Genes &amp; Development, 16 (15 ), 1890–1905. doi:10.1101/gad.1004802 12154121
Weil D , Piton A , Lessel D , &amp; Standart N (2020). Mutations in genes encoding regulators of mRNA decapping and translation initiation: links to intellectual disability. Biochemical Society Transactions, 48 (3 ), 1199–1211. doi:10.1042/BST20200109 32412080
Weyn-Vanhentenryck SM , Feng H , Ustianenko D , Duffié R , Yan Q , Jacko M , . . . Zhang C (2018). Precise temporal regulation of alternative splicing during neural development. Nature Communications, 9 (1 ), 2189. doi:10.1038/s41467-018-04559-0
Wieloch T (1985). Neurochemical Correlates to Selective Neuronal Vulnerability. In Kogure K , Hossmann KA , Siesjö BK , &amp; Welsh FA (Eds.), Progress in Brain Research (Vol. 63 , pp. 69–85): Elsevier.2872696
Wu Q , &amp; Maniatis T (1999). A Striking Organization of a Large Family of Human Neural Cadherin-like Cell Adhesion Genes. Cell, 97 (6 ), 779–790. doi:10.1016/S0092-8674(00)80789-8 10380929
Wu Q , Zhang T , Cheng J-F , Kim Y , Grimwood J , Schmutz J , . . . Maniatis T (2001). Comparative DNA Sequence Analysis of Mouse and Human Protocadherin Gene Clusters. Genome Research, 11 (3 ), 389–404. doi:10.1101/gr.167301 11230163
Xie X , Lu J , Kulbokas EJ , Golub TR , Mootha V , Lindblad-Toh K , . . . Kellis M (2005). Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature, 434 (7031 ), 338–345. doi:10.1038/nature03441 15735639
Xue Y , Zhou Y , Wu T , Zhu T , Ji X , Kwon Y-S , . . . Zhang Y (2009). Genome-wide Analysis of PTB-RNA Interactions Reveals a Strategy Used by the General Splicing Repressor to Modulate Exon Inclusion or Skipping. Molecular Cell, 36 (6 ), 996–1006. doi:10.1016/j.molcel.2009.12.003 20064465
Yang E , van Nimwegen E , Zavolan M , Rajewsky N , Schroeder M , Magnasco M , &amp; Darnell JE (2003). Decay Rates of Human mRNAs: Correlation With Functional Characteristics and Sequence Attributes. Genome Research, 13 (8 ), 1863–1872. doi:10.1101/gr.1272403 12902380
Yang YYL , Yin GL , &amp; Darnell RB (1998). The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proceedings of the National Academy of Sciences, 95 (22 ), 13254–13259. doi:10.1073/pnas.95.22.13254
Yano M , Hayakawa-Yano Y , Mele A , &amp; Darnell RB (2010). Nova2 Regulates Neuronal Migration through an RNA Switch in Disabled-1 Signaling. Neuron, 66 (6 ), 848–858. doi:10.1016/j.neuron.2010.05.007 20620871
Yap K , Xiao Y , Friedman Brad A. , Je HS , &amp; Makeyev Eugene V . (2016). Polarizing the Neuron through Sustained Co-expression of Alternatively Spliced Isoforms. Cell Reports, 15 (6 ), 1316–1328. doi:10.1016/j.celrep.2016.04.012 27134173
Yasui DH , Peddada S , Bieda MC , Vallero RO , Hogart A , Nagarajan RP , . . . LaSalle JM . (2007). Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proceedings of the National Academy of Sciences, 104 (49 ), 19416–19421. doi:10.1073/pnas.0707442104
Yazdani M , Deogracias R , Guy J , Poot RA , Bird A , &amp; Barde Y-A (2012). Disease Modeling Using Embryonic Stem Cells: MeCP2 Regulates Nuclear Size and RNA Synthesis in Neurons. Stem Cells, 30 (10 ), 2128–2139. doi:10.1002/stem.1180 22865604
Young JI , Hong EP , Castle JC , Crespo-Barreto J , Bowman AB , Rose MF , . . . Zoghbi HY (2005). Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proceedings of the National Academy of Sciences, 102 (49 ), 17551–17558. doi:10.1073/pnas.0507856102
Zeisel A , Hochgerner H , Lönnerberg P , Johnsson A , Memic F , van der Zwan J , . . . Linnarsson S (2018). Molecular Architecture of the Mouse Nervous System. Cell, 174 (4 ), 999–1014.e1022. doi:10.1016/j.cell.2018.06.021 30096314
Zeisel A , Muñoz-Manchado Ana B , Codeluppi S , Lönnerberg P , La Manno G , Juréus A , . . . Linnarsson S (2015). Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science, 347 (6226 ), 1138–1142. doi:10.1126/science.aaa1934 25700174
Zeng H , &amp; Sanes JR (2017). Neuronal cell-type classification: challenges, opportunities and the path forward. Nature Reviews Neuroscience, 18 (9 ), 530–546. doi:10.1038/nrn.2017.85 28775344
Zhang B , Wang W , Zhang Z , Hu Y , Meng F , Wang F , . . . Gao Z (2018). Alternative Splicing of Disabled-1 Controls Multipolar-to-Bipolar Transition of Migrating Neurons in the Neocortex. Cerebral Cortex, 28 (10 ), 3457–3467. doi:10.1093/cercor/bhx212 28968791
Zhang B , Wu Q , Cheng S , &amp; Li W (2021). Systematic Profiling of mRNA Splicing Reveals the Prognostic Predictor and Potential Therapeutic Target for Glioblastoma Multiforme. Journal of Oncology, 2021 , 4664955. doi:10.1155/2021/4664955 34326872
Zhang C , Zhang Z , Castle J , Sun S , Johnson J , Krainer AR , &amp; Zhang MQ (2008). Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes &amp; Development, 22 (18 ), 2550–2563. doi:10.1101/gad.1703108 18794351
Zhang M , Ergin V , Lin L , Stork C , Chen L , &amp; Zheng S (2019). Axonogenesis Is Coordinated by Neuron-Specific Alternative Splicing Programming and Splicing Regulator PTBP2. Neuron, 101 (4 ), 690–706.e610. doi:10.1016/j.neuron.2019.01.022 30733148
Zhang X , Chen MH , Wu X , Kodani A , Fan J , Doan R , . . . Walsh CA (2016). Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. Cell, 166 (5 ), 1147–1162.e1115. doi:10.1016/j.cell.2016.07.025 27565344
Zhang Y , Chen K , Sloan SA , Bennett ML , Scholze AR , Keeffe S , . . . Wu JQ (2014). An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex. The Journal of Neuroscience, 34 (36 ), 11929. doi:10.1523/JNEUROSCI.1860-14.2014 25186741
Zhao M , Kim JR , van Bruggen R , &amp; Park J (2018). RNA-Binding Proteins in Amyotrophic Lateral Sclerosis. Molecules and Cells, 41 (9 ), 818–829. doi:10.14348/molcells.2018.0243 30157547
Zheng S (2020). Alternative splicing programming of axon formation. WIREs RNA, 11 (4 ), e1585. doi:10.1002/wrna.1585 31922356
Zheng S , Gray EE , Chawla G , Porse BT , O’Dell TJ , &amp; Black DL (2012). PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2. Nature Neuroscience, 15 (3 ), 381–388. doi:10.1038/nn.3026 22246437
Zheng Y , Luo Y , Chen X , Li H , Huang B , Zhou B , . . . Geng W (2021). The role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors. Molecular Cancer, 20 (1 ), 49. doi:10.1186/s12943-021-01341-7 33673851
Zhou Z , Licklider LJ , Gygi SP , &amp; Reed R (2002). Comprehensive proteomic analysis of the human spliceosome. Nature, 419 (6903 ), 182–185. doi:10.1038/nature01031 12226669
